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ABSTRACT 
 
 
Ashley Leak: Factors Influencing non-Hodgkin Lymphoma Survivors’ Quality of Life 
(Under the direction of Deborah Mayer, PhD) 
 
 Non-Hodgkin lymphoma (NHL) is the most common hematologic malignancy. 
Survivors of NHL are living longer, and their adaptation to the disease long-term is a needed 
research area. Therefore, this retrospective, cross-sectional analysis using a preexisting data 
set (1) explored demographic and disease characteristics associated with quality of life 
(QOL) for NHL survivors, (2) tested a conceptual model to determine if adaptation to NHL 
mediated the relationship between the demographic and disease characteristics of that QOL, 
and (3) determined whether age moderated demographic and disease characteristics and 
examined their relationships with QOL. The model framework was adapted from the cancer 
survivor adaptation model (Naus, Ishler, Parrott, & Kovacs, 2009). It was proposed and 
tested to determine statistically significant relationships among the three components of 
cancer survivorship: personal characteristics, adaptation, and outcomes. The NHL survivors 
were predominantly Caucasian, married/living with a partner, 62 years old on average, and 
10 years past diagnosis on average. The second aim used a SEM model and provided 
adequate goodness-of-fit indices with direct effects from personal characteristics on QOL: 
current age, income, total comorbidity score, and years since diagnosis. The other three 
effects were partially mediated by either negative adaptation (comorbidity, years since 
diagnosis) or both negative adaptation and positive adaptation (current age). The remaining 
personal characteristics had no direct effects on QOL, but they had fully mediated effects 
iii 
 
through negative adaptation (bone marrow transplant), positive adaptation (gender), or both 
(education and current treatment status). A moderation model was used to determine how 
personal characteristics impacted QOL using age as a moderator for the third aim. The 
analyses included a comparison of younger (< 65 years of age) and older (> 65 years of age) 
participants and differences in interaction effects on them. Younger age was associated with 
a greater likelihood of being female, earning less than $30,000 annually, and poorer QOL 
outcomes. Income was most strongly correlated with age and was negatively associated with 
QOL for younger survivors. This study’s results suggest that both positive and negative 
perceptions mediate relationships between demographic and disease characteristics and QOL 
for NHL survivors.  
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CHAPTER 1 
INTRODUCTION 
 
Statement of the Problem 
 Non-Hodgkin lymphoma (NHL) is the sixth most common cancer in the United 
States (US) with more than 65, 540 new diagnoses expected in 2010. An estimated 20, 210 
deaths will occur due to NHL this year (Surveillance and Epidemiology and End Results, 
2010). The 5-year survival rate for all individuals diagnosed with NHL is 68%. This number 
will increase because survivors are living longer due to medical and pharmaceutical 
treatment advancements (National Cancer Institute [NCI], 2010). As survivorship numbers 
increase, so does the percentage of older adults managing both late- and long-term effects 
caused by their disease and treatment (Ganz, 2001). The increase in survivorship numbers 
has generated interest not only in exploring late- and long-term quality of life (QOL) issues, 
but also in characteristics that influence adaptation to living with the disease. 
 Non-Hodgkin lymphoma is the most common hematologic malignancy found in 
people diagnosed with cancer. The median age at time of diagnosis is 67, making advancing 
age the risk factor most associated with developing NHL (American Cancer Society, 2010). 
Lymphomas are not a single disease, but rather, a group of diseases that affect white cells of 
the lymphatic system. They can be slow growing (indolent) or fast growing (aggressive) and 
can be chronic illnesses with fluctuating remissions, exacerbations, and symptoms including 
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fevers, fatigue, weight loss, night sweats, and pain (NCI, 2010). There are two types of 
lymphoma: Hodgkin and non-Hodgkin. Approximately 80% of affected individuals are 
diagnosed with NHL (NCI, 2010). Treatment options for those diagnosed with NHL include 
chemotherapy, radiation, biotherapy (e.g., immunotherapy), hematopoietic transplantation, 
active surveillance, or a combination of those treatments. The most common first-line 
treatment of NHL is rituximab combined with cyclophosphamide, doxorubicin, vincristine, 
and prednisone (R-CHOP), which has improved the long-term outcomes of relapsed, 
untreated aggressive, or indolent NHLs (Czuczman, Weaver, Alkuzweny, Berlfein, & Grillo-
Lopez, 2004; Schulz et al., 2007). 
 The physiological and psychological changes that occur during the NHL survivorship 
journey can be stressful, potentially resulting in negative effects on health-related outcomes. 
Survivors often experience coexisting illnesses or comorbidities, a decline in physical 
functioning, psychological distress, or a combination of all those factors. They are all 
associated with improved or decreased QOL (Ganz, 2001), a widely accepted, patient-
reported outcome. Although there are different models of QOL, its common domains include 
physical, psychological, social, spiritual, and functional well-being (Cella et al., 1993; 
Ferrell, Hassey Dow, & Grant, 1995; Ferrell, Hassey Dow, Leigh, Ly, & Gulasekaram, 
1995). An NHL diagnosis and its treatment may have effects on QOL domains, which may 
differ according to each survivor’s individual characteristics. Survivors, specifically those 
who are elderly, represent a population for which adaptation to the disease remains 
understudied.  
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Purpose 
 Given that the incidence of NHL has increased in the past decade, especially among 
the older adult population, there is a need to understand NHL survivors’ adaptation process 
to living with their disease. Little literature to date examines the associations of personal 
characteristics with the adaptation to living with cancer among NHL survivors. This 
dissertation’s aims are to (1) explore demographic and disease characteristics associated with 
QOL for NHL survivors, (2) test a conceptual model to determine if adaptation to a cancer 
diagnosis mediates the relationship between the demographic and disease characteristics and 
QOL, and (3) determine whether age moderates demographic and disease characteristics’ 
effects on QOL and to examine their relationships with QOL.  
Conceptual Framework 
 The framework for this study is based on the cancer survivor adaptation model 
(CSA), derived from Naus, Ishler, Parrott, and Kovacs’s (2009) research. It has three 
components: personal characteristics, adaptation, and outcomes. The three variables that 
depict relationships between those components are represented in the CSA model: personal 
characteristics, adaptation during the illness, and cancer specific QOL outcomes (Figure 1.1). 
Personal characteristics include the biological, psychological, social, and spiritual factors 
that impact the cancer experience. Adaptation is the fundamental component of this model 
and is an ongoing, cognitive process involving continuous appraisal of the situation by the 
survivor (Naus et al., 2009). It is reflected as the positive and negative impact of cancer. 
Quality of life is the outcome of the model. The terms of this model and other terms in this 
dissertation are described in Table 1.1.  
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 Personal Characteristics   Adaptation   Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. The cancer survivor adaptation model illustrating the three components and three 
variables that affect positive and negative adaptations of survivors to their cancer diagnoses 
and treatments. Source: Adapted from Naus, Ishler, Parrott, and Kovacs, 2009. BMT/SCT = 
bone marrow transplantation/stem cell transplantation. 
 
All of these variables can influence survivors’ adaptations to cancer, and understanding their 
relationships will help to better address the multifaceted health needs of NHL survivors.  
 
Table 1.1. 
Key Terms and Definitions of Cancer Adaptation Model and of Study  
Key Term Definition  
Adaptation The appraisal of the situation as positive or negative coping with 
the cancer experience (Naus, Ishler, Parrott, & Kovacs, 2009). 
+
‐/+
‐‐
Quality of Life  
Physical 
Social/Family 
Functional 
 Emotional Well-Negative Adaptation 
 
Appearance Concerns 
Body Change Concerns 
Positive Adaptation 
 Altruism and Empathy 
Health Awareness  
Meaning of Cancer 
+
Demographics  
 
Age 
Gender 
Ethnicity 
Education 
Marital Status 
Medical Factors 
 
Comorbidities 
Cancer Treatments: 
surgery, radiation 
therapy, BMT/SCT, 
biologic  
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Impact of Cancer  The assessment of health-related quality of life to more fully 
understand the burden of cancer and the evaluative effects of 
cancer treatments (Zebrack, 2000). 
Non-Hodgkin 
Lymphoma 
Cancer consisting of malignant lymphocytes (National Cancer 
Institute [NCI], 2010).  
Older Adult Individuals aged 65 years and older in the United States who 
have reached retirement age per government regulations (World 
Health Organization, 2010).  
Personal 
Characteristics 
Inter- and intra-personal characteristics that include the 
biological, psychological, social, and spiritual factors that impact 
the cancer experience (Naus et al., 2009). 
Quality of Life A subjective, multidimensional construct that includes both 
positive and negative aspects of life. Its domains include 
physical, functional, social and familial, and emotional well-
being (Cella et al., 1993; Cella, Webster, & Cashy, 2005; Ware 
& Sherbourne, 1992).  
Survivor 
 
 
 
Survivorship 
A survivor is an individual from the time of cancer diagnosis 
through the balance of his or her life (National Coalition for 
Cancer Survivorship, n.d.). 
 
Survivorship is the physical, psychosocial, and economic issues 
of cancer from diagnosis until the end of life. It focuses on the 
health and life of an individual with cancer beyond the diagnosis 
and treatment phases. Survivorship includes issues related to the 
ability to get health care and follow-up treatment, late effects of 
treatment, second cancers, and quality of life (NCI, 2010).  
 
 
 
 
 
Summary 
 Chapters 2, 3, and 4 are three manuscripts that correspond to each specified aim of 
the study. Chapter 2, Manuscript 1, “Quality of Life Domains among NHL Survivors: An 
Integrative Literature Review,” is a review of NHL survivorship and QOL with an emphasis 
on older survivors. A comprehensive synthesis of the literature is provided. Chapter 3, 
Manuscript 2, “An Exploratory Mediation Model of the Relationships between Positive and 
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Negative Adaptation on QOL of NHL Survivors,” examines how adapting to cancer mediates 
the relationship between demographic and disease characteristics and the QOL of NHL 
survivors. Structural equation modeling (SEM) was used to test a CSA model based on 
cognitive appraisal theories (Naus et al., 2009). Chapter 4, Manuscript 3, “The Influence of 
Age on the QOL of NHL Survivors,” examines the effects of age on NHL survivors’ 
adaptation and QOL. A multiple regression analysis was used to determine the moderating 
effects of age on survivors’ QOL. Chapter 5 is a synthesis of the three manuscripts’ results 
with a focus on implications for future research and practice implementations. 
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CHAPTER 2 
 
QUALITY OF LIFE DOMAINS AMONG NHL SURVIVORS: AN INTEGRATIVE 
LITERATURE REVIEW 
 
 
Introduction 
 Non-Hodgkin lymphoma (NHL) is the sixth most common cancer in the United 
States (US), with more than 65,540 new NHL diagnoses and 20,210 deaths expected in 2010 
(American Cancer Society, 2010). Incidence and prevalence rates increase with age, and 
more than 70% of NHLs are diagnosed after the survivor is 55 years of age (American 
Cancer Society, 2010). The overall, 5-year survival rate is 68% (Horner, Ries, & Krapcho, 
2009). Belonging to a group of hematologic cancers, NHL affects the white cells within the 
lymphatic system. Lymphomas can be slow growing (indolent) or aggressive (fast-growing). 
Individuals with HIV-associated NHL are more likely to have high-grade histology and 
respond poorly to treatment (Cote et al., 1997). In addition, NHL is a chronic illness with 
fluctuating remissions and exacerbations with varying symptoms: fevers, fatigue, weight 
loss, night sweats, and even localized pain dependent on the involvement of the tumors 
(National Cancer Institute, 2010). In fact, many survivors live with the disease for years and 
are often diagnosed during routine examinations (Hamblin, 2011).  
 In general, cancer is no longer synonymous with a death sentence; some types are 
viewed as manageable, chronic conditions, which is frequently the case with NHL. This is 
reflected in the change of terminology associated with cancer care. For example, individuals 
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with cancer are no longer perceived as victims but instead as survivors who live for years 
following a cancer diagnosis (Aziz & Rowland, 2003; Bloom, 2002). Although survivorship 
is often celebrated, cancer has a significant impact on survivors in terms of long-term health 
and psychosocial sequelae (Aziz & Rowland, 2003; Brown et al, 2003; Centers for Disease 
Control and Prevention, 2004; Ganz, 2001; Jemal et al., 2004). For example, cancer survivors 
are at increased risk for developing secondary malignancies and other diseases (e.g., 
cardiovascular disease, diabetes, osteoporosis; (Brown, et al., 2003; Centers for Disease 
Control and Prevention, 2004; Jemal et al., 2004, Bolin, 2008). In addition, Hewitt, Rowland, 
and Yancik (2003) reported that cancer survivors have almost a twofold greater likelihood of 
having at least one functional limitation than those without cancer.  
 The presence of one or more coexisting conditions or ailments in addition to a 
primary disease such as cancer is known as a comorbidity (Yancik, Ganz,  Varicchio & 
Conley, 2001; Yancik, Havlik, & Wesley, 1996). When a survivor has another comorbid 
condition, they may experience a decline in functional status that can negatively influence 
their QOL. These comorbid conditions become more prevalent as people age, complicating 
the illness trajectory of NHL. However, the psychosocial and QOL needs of older adults with 
NHL remain understudied (National Cancer Institute, 2010). Because little data exist on older 
NHL survivors and the effects of various treatments on their QOL, it is important to 
understand their QOL domains to better address their needs. The purpose of this paper is to 
provide an integrative review that reports the science that has been used for determining 
QOL among older NHL survivors. The review was focused on QOL measures and treatment 
effects in the identified studies.  
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Methods 
 Articles were retrieved for review via a combination of computer and manual 
searches of selected QOL and cancer-related publications. A comprehensive, online database 
search of Medline, Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
PsycINFO, and the Cochrane Library was conducted for NHL research articles published 
between January 2000 and April 2010. The following search terms were used alone and in 
combination: non-Hodgkin lymphoma, health-related quality of life, quality of life, and 
impact of cancer.  
 Because there is a paucity of data regarding the QOL of older NHL survivors, studies 
that included younger NHL survivors and those with subsamples of NHL survivors were 
used in this analysis. However, there was a lack of clarity in age delineation in several 
studies, but it is assumed for this paper that individuals 65 years of age and older are older 
adults as per Medicare requirements, unless explicitly stated otherwise (Mols, Coebergh, & 
van de Poll-Franse, 2007). Except for Mols, Coebergh, and van der Poll-Franse (2007), no 
studies delineated age in their analyses.  
 Articles focused on central nervous system and T-cell cutaneous lymphomas were 
excluded because their treatment and clinical courses differ from other NHL subtypes 
(National Comprehensive Cancer Network, 2010). Additionally, publications lacking a 
standardized QOL-related outcome measure were excluded. Articles were retrieved in the 
English language, and publication types were limited to primary research reports and 
systematic reviews. Editorials, opinions, and case studies were excluded.  
 Articles were initially reviewed by abstracts and titles, yielding 42 abstracts from 
Medline, 143 abstracts from CINAHL, 12 abstracts from PsycINFO, and no abstracts from 
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the Cochrane Library. Duplicate articles were excluded as were abstracts that did not meet 
the inclusion criteria. The full texts of the remaining 98 articles were read. Eighteen articles 
met the inclusion criteria and were selected for review. Each article was critiqued and 
appraised for the quality of the research evidence in relation to the QOL of NHL survivors. 
Results of the Literature Review 
General Characteristics  
 The full list of reviewed studies and general characteristics are presented on Table 
2.1. The majority (n = 15) of the selected studies were published within the past 5 years. 
Twelve of the studies were based in the US, which has a larger cancer database and registry 
than those in the countries of the remaining studies: Netherlands (n = 2), Canada (n = 1), 
Israel (n = 1), and the United Kingdom (n = 1). Seventeen of the studies were descriptive, 
used a cross-sectional design with varying age ranges, and reported on the number of years 
postdiagnosis. Sociodemographic characteristics were homogeneous across all the studies. 
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at
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 C
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, m
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, m
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at
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 o
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at
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 .0
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at
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 .0
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 c
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, l
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r o
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 c
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R
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R
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 c
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 c
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ra
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 o
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 re
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, C
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 b
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 o
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 .0
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at
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 c
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s o
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 m
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, m
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 C
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at
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is
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 p
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l c
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 .0
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, b
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 o
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s o
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pa
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 d
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 p
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m
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, C
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 m
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 re
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 re
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f p
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 b
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r m
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.0
01
 
St
re
ng
th
s:
 F
irs
t t
o 
de
sc
rib
e 
ex
er
ci
se
 
be
ha
vi
or
 in
 N
H
L 
sv
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re
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 C
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 re
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ra
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.9
 
SD
 (1
4.
2)
, 
2–
44
 y
ea
rs
 
po
st
di
ag
no
si
s. 
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R
el
ia
bi
lit
y 
an
d 
va
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 b
re
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 d
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 b
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 o
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s f
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s o
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 d
iff
er
 
be
tw
ee
n 
H
IV
+ 
an
d 
H
IV
- 
N
H
L 
sv
rs
.  
St
re
ng
th
s:
 N
H
L 
su
bg
ro
up
s w
ith
 
an
d 
w
ith
ou
t H
IV
 
fo
r c
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R
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 .0
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R
el
at
ed
 
M
ea
su
re
s 
Fi
nd
in
gs
 
St
re
ng
th
s a
nd
 
L
im
ita
tio
ns
 
M
ol
s, 
C
oe
be
rg
h,
 &
 
va
n 
de
 P
ol
l-
Fr
an
se
 
(2
00
7)
  
 
C
ro
ss
-
se
ct
io
na
l; 
Ei
nd
ho
ve
n 
C
an
ce
r 
R
eg
is
try
, 
N
et
he
rla
nd
s  
C
om
pa
re
d 
H
R
Q
O
L 
an
d 
he
al
th
 c
ar
e 
ut
ili
za
tio
n 
of
 lo
ng
-
te
rm
 c
an
ce
r s
vr
s. 
us
in
g 
po
pu
la
tio
n-
ba
se
d 
st
ud
y 
co
m
pa
rin
g 
sv
rs
. o
ve
r 
an
d 
un
de
r 7
0 
ye
ar
s 
of
 a
ge
 
N
 =
 2
94
 N
H
L 
sv
rs
. m
ed
ia
n 
ag
e 
= 
53
 y
ea
rs
 fo
r 
N
H
L 
sv
rs
. <
 7
0,
 
m
ed
ia
n 
ag
e 
= 
76
 
ye
ar
s f
or
 N
H
L 
sv
rs
. >
 7
0,
 5
-–
15
 
ye
ar
s 
po
st
di
ag
no
si
s. 
Su
rg
er
y:
 n
 =
 2
8,
 
R
T:
 n
 =
 1
02
, C
T:
 
n 
= 
16
0 
, 
W
at
ch
fu
l 
w
ai
tin
g:
 n
 =
 1
6 
SF
-3
6 
 
N
H
L 
sv
rs
. h
ad
 lo
w
er
 sc
or
es
 
fo
r g
en
er
al
 h
ea
lth
 p
er
ce
pt
io
n 
an
d 
vi
ta
lit
y 
co
m
pa
re
d 
to
 th
e 
no
rm
at
iv
e 
po
pu
la
tio
n 
(p
 <
 
.0
01
). 
O
ld
er
 a
ge
, ≥
 1
 
co
m
or
bi
d 
di
se
as
e,
 lo
w
er
 
ed
uc
at
io
na
l l
ev
el
, a
nd
 
cu
rr
en
t o
cc
up
at
io
n 
ha
d 
po
or
er
 H
R
Q
O
L 
(p
 <
 .0
1)
. 
> 
70
-y
ea
rs
-o
ld
 N
H
L 
sv
rs
. 
vi
si
te
d 
th
ei
r o
nc
ol
og
is
t m
or
e 
th
an
 th
ei
r P
C
P 
w
he
n 
co
m
pa
re
d 
to
 <
 7
0 
ye
ar
s, 
p 
< 
0.
01
 
 
St
re
ng
th
s:
 W
or
k 
ch
an
ge
s/
pa
tte
rn
s 
ex
is
t i
n 
lo
ng
-te
rm
 
sv
rs
.; 
w
or
k 
ch
an
ge
 c
or
re
la
te
d 
w
ith
 H
R
Q
O
L 
 Li
m
ita
tio
ns
: 
C
ro
ss
-s
ec
tio
na
l, 
lim
ite
d 
fo
llo
w
-u
p,
 
no
 c
on
ce
pt
ua
l 
fr
am
ew
or
k 
Pe
tte
ng
el
l, 
D
on
at
ti,
 &
 
H
os
ki
n 
(2
00
8)
  
C
ro
ss
-
se
ct
io
na
l, 
U
ni
te
d 
K
in
gd
om
  
Ex
pl
or
e 
re
la
tio
ns
hi
p 
be
tw
ee
n 
di
se
as
e 
ac
tiv
ity
 a
nd
 h
ea
lth
 
fu
nc
tio
ni
ng
 o
n 
H
R
Q
O
L 
N
 =
 2
22
 
fo
lli
cu
la
r 
ly
m
ph
om
a,
 
m
ed
ia
n 
ag
e 
60
.4
 
ye
ar
s (
SD
 =
 1
0.
6)
 
   
FA
C
T-
Ly
m
 
Sv
rs
. w
ho
 re
la
ps
ed
 h
ad
 
w
or
se
 Q
O
L 
an
d 
ph
ys
ic
al
 a
nd
 
m
en
ta
l f
un
ct
io
ni
ng
 
co
m
pa
re
d 
to
 n
ew
ly
 
di
ag
no
se
d,
 in
 p
ar
tia
l o
r 
co
m
pl
et
e 
re
m
is
si
on
, o
r 
di
se
as
e-
fr
ee
 sv
rs
.  
St
re
ng
th
s:
 H
ea
lth
 
ou
tc
om
es
 
re
po
rte
d 
at
 
di
ff
er
en
t c
an
ce
r 
st
ag
es
, l
ar
ge
 
sa
m
pl
e 
 
 Li
m
ita
tio
ns
: 
Su
bg
ro
up
s w
er
e 
sm
al
l, 
cr
os
s-
se
ct
io
na
l, 
no
 
co
nc
ep
tu
al
 
fr
am
ew
or
k 
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A
ut
ho
rs
 
D
es
ig
n 
Pu
rp
os
e 
Sa
m
pl
e 
C
ha
ra
ct
er
is
tic
s 
Q
O
L
- 
R
el
at
ed
 
M
ea
su
re
s 
Fi
nd
in
gs
 
St
re
ng
th
s a
nd
 
L
im
ita
tio
ns
 
R
ee
ve
 e
t a
l. 
(2
00
9)
  
C
ro
ss
-
se
ct
io
na
l; 
SE
ER
 d
at
a 
an
d 
M
H
O
S,
 
19
98
–2
00
3 
Q
ua
nt
ify
 e
xt
en
t o
f 
H
R
Q
O
L 
ch
an
ge
s 
be
fo
re
 a
nd
 a
fte
r 
ca
nc
er
 d
ia
gn
os
is
 
N
 =
 1
,4
32
 
pr
os
ta
te
, b
re
as
t, 
co
lo
re
ct
al
, l
un
g,
 
bl
ad
de
r, 
en
do
m
et
ria
l, 
ki
dn
ey
, 
m
el
an
om
a,
 a
nd
 
N
H
L 
sv
rs
.; 
m
ea
n 
ag
e 
73
.8
6 
SD
 =
 
5.
85
; m
ea
n 
tim
e 
fr
om
 d
ia
gn
os
is
 to
 
fo
llo
w
-u
p 
M
H
O
S 
w
as
 1
2.
4 
m
on
th
s. 
Tr
ea
tm
en
ts
 n
ot
 
di
sc
us
se
d 
 
SF
-3
6 
 
N
H
L 
sv
rs
. (
n 
= 
53
) h
ad
 th
e 
gr
ea
te
st
 d
ec
lin
e 
in
 p
hy
si
ca
l 
he
al
th
 c
om
pa
re
d 
to
 o
th
er
 
ca
nc
er
s;
 N
H
L 
sv
rs
. h
ad
 
lo
w
er
ed
 v
ita
lit
y 
an
d 
de
cr
ea
se
 
in
 so
ci
al
 fu
nc
tio
n 
St
re
ng
th
s:
 L
ar
ge
, 
fo
cu
se
d 
ol
de
r 
ad
ul
t s
am
pl
e;
 
sv
rs
. s
ur
ve
y 
da
ta
 
lin
ke
d 
w
ith
 S
EE
R
 
da
ta
; e
va
lu
at
ed
 
H
R
Q
O
L 
be
fo
re
 
an
d 
af
te
r c
an
ce
r 
di
ag
no
si
s  
 Li
m
ita
tio
ns
: 
M
ed
ic
ar
e 
m
an
ag
ed
-p
la
n 
sv
rs
., 
sa
m
pl
e 
si
ze
 
w
as
 sm
al
l f
or
 
N
H
L 
sv
rs
., 
un
ab
le
 to
 c
on
du
ct
 
H
R
Q
O
L 
fo
llo
w
-
up
 su
rv
ey
 (d
ea
th
s, 
un
en
ro
lle
d 
fr
om
 
pl
an
), 
no
 
co
nc
ep
tu
al
 
fr
am
ew
or
k 
21
   
A
ut
ho
rs
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Sa
m
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er
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s 
Q
O
L
- 
R
el
at
ed
 
M
ea
su
re
s 
Fi
nd
in
gs
 
St
re
ng
th
s a
nd
 
L
im
ita
tio
ns
 
Sm
ith
, 
C
re
sp
i, 
Pe
te
rs
en
, 
Zi
m
m
er
m
an
 
&
 G
an
z 
(2
01
0)
  
C
ro
ss
-
se
ct
io
na
l, 
N
C
 
C
an
ce
r 
R
eg
is
try
 
Ex
am
in
e 
th
e 
as
so
ci
at
io
n 
be
tw
ee
n 
th
e 
IO
C
 v
2 
sc
al
es
 
an
d 
ou
tc
om
es
 in
 a
 
la
rg
e 
sa
m
pl
e 
of
 a
du
lt 
N
H
L 
sv
rs
. 
N
 =
 6
52
 N
H
L 
sv
rs
., 
m
ed
ia
n 
ag
e 
at
 st
ud
y 
en
ro
llm
en
t =
 
62
.7
 y
ea
rs
, m
ea
n 
ag
e 
at
 d
ia
gn
os
is
 
= 
51
.9
 y
ea
rs
 (S
D
 
= 
14
.2
), 
m
ea
n 
tim
e 
fr
om
 
di
ag
no
si
s t
o 
st
ud
y 
en
ro
llm
en
t 
= 
10
.8
 y
ea
rs
, (
SD
 
= 
7.
5)
. R
T:
 4
8%
, 
C
T:
 8
2%
  
IO
C
, S
F-
36
, F
A
C
T-
G
 
Sv
rs
. w
ho
 w
er
e 
no
n-
C
au
ca
si
an
, w
ith
ou
t a
 c
ol
le
ge
 
de
gr
ee
, u
ne
m
pl
oy
ed
, 
yo
un
ge
r a
t s
tu
dy
 e
nr
ol
lm
en
t, 
ha
d 
co
m
or
bi
d 
co
nd
iti
on
s o
r 
le
ss
 so
ci
al
 su
pp
or
t h
ad
 w
or
se
 
Q
O
L 
w
he
n 
co
nt
ro
lle
d 
fo
r 
ot
he
r v
ar
ia
bl
es
; s
vr
s. 
w
ith
 
co
m
or
bi
di
tie
s a
nd
 n
eg
at
iv
e 
ap
pr
ai
sa
l r
ep
or
te
d 
w
or
se
 
ph
ys
ic
al
 a
nd
 m
en
ta
l h
ea
lth
 
(p
 <
 .0
5)
  
St
re
ng
th
s:
 
V
al
id
at
io
n 
of
 IO
C
 
v2
; h
ea
lth
 st
at
us
, 
fu
nc
tio
ni
ng
, a
nd
 
Q
O
L 
in
 la
rg
e 
sa
m
pl
e 
of
 N
H
L 
sv
rs
.; 
br
oa
d 
de
m
og
ra
ph
ic
 
pr
of
ile
; h
ig
h 
re
sp
on
se
 ra
te
 
(7
4%
) 
 Li
m
ita
tio
ns
: 
C
ro
ss
-s
ec
tio
na
l, 
2 
N
C
 
C
om
pr
eh
en
si
ve
 
C
an
ce
r C
en
te
rs
, 
no
 c
on
ce
pt
ua
l 
fr
am
ew
or
k 
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D
es
ig
n 
Pu
rp
os
e 
Sa
m
pl
e 
C
ha
ra
ct
er
is
tic
s 
Q
O
L
- 
R
el
at
ed
 
M
ea
su
re
s 
Fi
nd
in
gs
 
St
re
ng
th
s a
nd
 
L
im
ita
tio
ns
 
Sm
ith
, 
Zi
m
m
er
m
an
, 
W
ill
ia
m
s, 
Pr
ei
ss
er
, &
 
C
lip
p 
(2
00
8)
 
C
ro
ss
-
se
ct
io
na
l, 
N
C
 
C
an
ce
r 
R
eg
is
try
  
Es
tim
at
e 
pr
ev
al
en
ce
 
of
 P
TS
D
 sy
m
pt
om
s 
in
 sv
rs
. o
f a
du
lt 
N
H
L 
w
ho
 a
re
 a
t l
ea
st
 2
 
ye
ar
s p
os
td
ia
gn
os
is
 
an
d 
id
en
tif
y 
ris
k 
fa
ct
or
s a
ss
oc
ia
te
d 
w
ith
 P
TS
D
 
sy
m
pt
om
s 
N
 =
 8
86
 N
H
L 
sv
rs
, m
ed
ia
n 
ag
e 
= 
52
.6
 y
ea
rs
 
(r
an
ge
 =
 2
5–
92
), 
2–
44
 y
ea
rs
 
po
st
di
ag
no
si
s. 
N
o 
tre
at
m
en
t: 
5%
, S
ur
ge
ry
: 
28
%
, R
T:
 4
7%
, 
C
T:
 7
8%
, 
B
M
T/
SC
T:
 
14
.9
%
, b
io
lo
gi
c 
th
er
ap
y:
 2
9.
5%
 
PC
L-
C
, 
M
ed
ic
al
 
O
ut
co
m
es
 
St
ud
y-
 
So
ci
al
 
Su
pp
or
t 
Su
rv
ey
  
  
8%
 o
f s
vr
s. 
m
et
 P
TS
D
 
di
ag
no
st
ic
 c
rit
er
ia
 a
nd
 3
9%
 
ha
d 
PT
SD
 sy
m
pt
om
s;
 th
e 
im
pa
ct
 o
f a
 c
an
ce
r d
ia
gn
os
is
 
an
d 
tre
at
m
en
t p
er
si
st
s f
or
 
ye
ar
s f
or
 m
an
y 
sv
rs
; p
os
iti
ve
 
as
so
ci
at
io
n 
be
tw
ee
n 
so
ci
al
 
su
pp
or
t a
nd
 Q
O
L,
 p
 <
 .0
01
 
  
St
re
ng
th
s:
 
Ex
am
in
ed
 P
TS
D
 
w
el
l-b
ei
ng
 o
f 
lo
ng
-te
rm
 N
H
L 
sv
rs
, l
ar
ge
 sa
m
pl
e 
w
ith
 a
ge
 ra
ng
e 
of
 
25
–9
2,
 u
se
 o
f 
La
za
ru
s &
 
Fo
lk
m
an
 (1
98
4)
 
PT
SD
 c
on
ce
pt
ua
l 
fr
am
ew
or
k 
 Li
m
ita
tio
ns
: N
o 
co
m
pa
ris
on
 
gr
ou
p;
 c
ro
ss
-
se
ct
io
na
l; 
sv
rs
. 
tre
at
ed
 a
t 2
 la
rg
e,
 
co
m
pr
eh
en
si
ve
 
ca
nc
er
 c
en
te
rs
 in
 
So
ut
he
as
te
rn
 
re
gi
on
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D
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Sa
m
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C
ha
ra
ct
er
is
tic
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Q
O
L
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R
el
at
ed
 
M
ea
su
re
s 
Fi
nd
in
gs
 
St
re
ng
th
s a
nd
 
L
im
ita
tio
ns
 
Sm
ith
, 
Zi
m
m
er
m
an
, 
W
ill
ia
m
s, 
&
 
Ze
br
ac
k 
(2
00
9)
  
C
ro
ss
-
se
ct
io
na
l, 
N
C
 C
an
ce
r 
R
eg
is
try
 
C
om
pa
re
 Q
O
L 
st
at
us
 
of
 th
os
e 
w
ith
 a
ct
iv
e 
N
H
L 
to
 th
at
 o
f t
ho
se
 
w
ho
 a
re
 d
is
ea
se
-f
re
e,
 
bo
th
 sh
or
t-t
er
m
 (2
–4
 
ye
ar
s)
 a
nd
 lo
ng
-te
rm
 
(≥
 5
 y
ea
rs
) 
po
st
di
ag
no
si
s 
N
 =
 7
61
 N
H
L 
sv
rs
, M
ed
ia
n 
ag
e 
= 
62
.7
 y
ea
rs
 
(r
an
ge
 =
 2
5–
92
), 
2–
44
 y
ea
rs
 
po
st
di
ag
no
si
s. 
Su
rg
er
y:
 3
0.
5%
, 
R
T:
 4
7.
8%
, C
T:
 
81
.1
%
, 
B
M
T/
SC
T:
 
15
.6
%
, B
io
lo
gi
c 
th
er
ap
y:
 2
8.
3%
  
SF
-3
6,
 
FA
C
T-
Ly
m
, I
O
C
 
Sv
rs
. w
ith
 a
ct
iv
e 
di
se
as
e 
ha
d 
w
or
se
 p
hy
si
ca
l a
nd
 m
en
ta
l 
he
al
th
 fu
nc
tio
ni
ng
, w
or
se
 
Q
O
L,
 a
nd
 le
ss
 p
os
iti
ve
 a
nd
 
m
or
e 
ne
ga
tiv
e 
IO
C
s 
co
m
pa
re
d 
w
ith
 d
is
ea
se
-f
re
e 
sv
rs
., 
p 
< 
.0
01
 
 
St
re
ng
th
s:
 L
ar
ge
 
sa
m
pl
e,
 la
rg
e 
ol
de
r a
du
lt 
po
pu
la
tio
n,
 u
se
 o
f 
La
za
ru
s &
 
Fo
lk
m
an
 (1
98
4)
 
an
d 
ca
nc
er
 
su
rv
iv
or
sh
ip
 
ba
se
d 
on
 c
op
in
g 
th
eo
rie
s 
co
nc
ep
tu
al
 
fr
am
ew
or
k 
  Li
m
ita
tio
ns
: 
C
ro
ss
-s
ec
tio
na
l, 
2 
la
rg
e 
co
m
pr
eh
en
si
ve
 
ca
nc
er
 c
en
te
rs
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C
ha
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ct
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Q
O
L
- 
R
el
at
ed
 
M
ea
su
re
s 
Fi
nd
in
gs
 
St
re
ng
th
s a
nd
 
L
im
ita
tio
ns
 
V
al
la
nc
e,
 
C
ou
rn
ey
a,
 
Jo
ne
s, 
&
 
R
ei
m
an
  
(2
00
5)
 
C
ro
ss
-
se
ct
io
na
l; 
re
tro
sp
ec
tiv
e 
su
rv
ey
; 
C
an
ad
a 
 
1.
 E
xa
m
in
e 
di
ff
er
en
ce
s i
n 
Q
O
L 
be
tw
ee
n 
N
H
L 
sv
rs
. 
w
ho
 m
ee
t/d
o 
no
t 
m
ee
t e
xe
rc
is
e 
gu
id
el
in
es
 
2.
 E
xa
m
in
e 
ex
er
ci
se
 
be
ha
vi
or
 c
ha
ng
es
 
ac
ro
ss
 tr
ea
tm
en
t  
N
 =
 4
38
 N
H
L 
sv
rs
., 
m
ea
n 
ag
e 
61
.1
 y
ea
rs
 (S
D
 =
 
13
.1
). 
C
T:
 
64
.6
%
, R
T:
 
10
.7
%
, C
T 
+ 
R
T:
 
15
.5
%
, S
ur
ge
ry
: 
3.
6%
, 
Im
m
un
ot
he
ra
py
: 
0.
9%
, B
M
T:
 
25
.2
%
, W
at
ch
fu
l 
w
ai
tin
g:
 1
7.
1%
 
 
FA
C
T-
A
n 
N
H
L 
sv
rs
. (
n 
= 
23
) w
ho
 m
et
 
th
e 
pu
bl
ic
 h
ea
lth
 e
xe
rc
is
e 
gu
id
el
in
es
 h
ad
 b
et
te
r 
ph
ys
ic
al
 fu
nc
tio
ni
ng
 (l
es
s 
fa
tig
ue
), 
fe
w
er
 a
ne
m
ia
 
re
la
te
d 
sy
m
pt
om
s, 
be
tte
r 
m
en
ta
l f
un
ct
io
ni
ng
 th
an
 
th
os
e 
th
at
 d
id
 n
ot
 m
ee
t t
he
 
gu
id
el
in
es
 (n
 =
 3
32
) 
St
re
ng
th
s:
 L
ar
ge
 
po
pu
la
tio
n 
ba
se
 o
f N
H
L 
sv
rs
, 
us
e 
of
 w
el
l-
es
ta
bl
is
he
d 
m
ea
su
re
s  
 Li
m
ita
tio
ns
: 
Se
le
ct
io
n 
bi
as
, 
re
ca
ll 
bi
as
 re
la
te
d 
to
 le
ng
th
 o
f l
on
g-
te
rm
 
su
rv
iv
or
sh
ip
, s
el
f-
 
re
po
rt 
of
 e
xe
rc
is
e,
 
ob
se
rv
at
io
na
l 
st
ud
y,
 n
o 
co
nc
ep
tu
al
 
fr
am
ew
or
k 
 
Ze
br
ac
k 
(2
00
0)
 
C
ro
ss
-
se
ct
io
na
l, 
fa
ce
-to
-f
ac
e 
se
m
is
tru
ct
ur
ed
 
in
te
rv
ie
w
s, 
C
al
ifo
rn
ia
  
Ex
am
in
e 
Q
O
L 
of
 
le
uk
em
ia
 a
nd
 
ly
m
ph
om
a 
lo
ng
-te
rm
 
sv
rs
 
N
 =
 5
3 
lo
ng
-te
rm
 
sv
rs
, n
 =
 2
5 
ly
m
ph
om
a 
sv
rs
., 
m
ed
ia
n 
ag
e 
at
 
di
ag
no
si
s:
 1
7,
 
av
er
ag
e 
ye
ar
s 
po
st
di
ag
no
si
s:
 
18
, t
re
at
m
en
ts
 
no
t d
is
cu
ss
ed
  
Q
O
L-
C
S 
Ly
m
ph
om
a 
sv
rs
 re
po
rte
d 
po
si
tiv
e 
ex
pe
rie
nc
es
 fr
om
 
th
ei
r c
an
ce
r, 
un
ce
rta
in
tie
s 
ab
ou
t t
he
 fu
tu
re
 w
er
e 
as
so
ci
at
ed
 w
ith
 d
ec
re
as
ed
 
Q
O
L,
 sp
iri
tu
al
/e
xi
st
en
tia
l 
Q
O
L 
do
m
ai
n 
re
fle
ct
ed
 th
at
 
ha
vi
ng
 a
 p
ur
po
se
 in
 li
fe
 is
 
cr
iti
ca
l i
n 
su
rv
iv
al
  
St
re
ng
th
s:
 
Q
ua
lit
at
iv
e 
de
sc
rip
tio
n 
of
 
qu
al
ity
 o
f l
ife
, 
m
ix
ed
 m
et
ho
ds
 
ap
pr
oa
ch
  
 Li
m
ita
tio
ns
: 
C
ro
ss
-s
ec
tio
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Quality of Life Measures  
 It is generally agreed that QOL is a subjective, multidimensional construct with both 
positive and negative aspects (Cella, Tulsky et al., 1993). The domains typically measured 
are physical, psychological, social, functional, and spiritual/existential. Each will be 
addressed in this paper. Instruments used to measure the domains vary, with the physical 
domain being included most often. No QOL instrument is accepted consistently as a gold 
standard for measurement (Donnelly, 2000). As shown in Table 2.2, half of the studies (n = 
9) used more than one QOL outcome measure. Additional instruments not included in Table 
2.2 included the Functional Assessment of HIV Infection (Diamond, Taylor, & Anton-
Culver, 2010), the Medical Outcomes Study-Social Support (Sherbourne & Stewart, 1991), 
Life Impact (Bellizzi, Miller, Arora, & Rowland, 2007), the Post-traumatic Stress Disorder 
(PTSD) Inventory (Geffen, Blaustein, Amir, & Cohen, 2003), and the PTSD Checklist-
Civilian Version (Smith, Zimmerman, Williams, Preisser, & Clipp, 2008). 
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Physical Well-Being 
  Multiple chronic conditions can affect functional abilities and decrease a person’s 
ability to maintain a healthy lifestyle. Using the Impact of Cancer (IOC) scale, Zebrack, Yi, 
Petersen, and Ganz (2008) measured QOL in a sample of individuals with cancer, including 
49 lymphoma survivors, who were 5 to 10 years postdiagnosis (n = 193). They found that 
older adults reported better overall QOL (p = .004) but worse physical health (p = .04) than 
their younger counterparts. Lower income (p = .02) and comorbidities (p = .003) were 
associated with worse physical functioning. A higher negative impact summary score was 
associated with worse physical functioning (p < .0001), worse mental health (p < .0001), and 
lower overall QOL (p < .0001).  
 These findings are consistent with Smith, Zimmerman, Williams, Preisser, and 
Clipp’s (2008) results. They measured NHL survivors’ (n = 652) QOL and found that 
survivors who were non-Caucasian, without a college degree, unemployed, younger at study 
enrollment, or who had comorbid conditions or less social support also had lower QOL. In a 
related study, survivors with active NHL disease were found to have worse physical 
functioning and QOL than disease-free survivors (Smith, Zimmerman, Williams, & Zebrack, 
2009). 
 Although cancer-related detriments to physical functioning are common, it has been 
shown that healthy behaviors such as physical activity can improve QOL and reduce 
symptoms such as fatigue in cancer survivors (Pinto, Rabin, Abdow, & Papandonatos, 2008). 
In a cross-sectional study of 438 NHL survivors, differences in overall QOL were found 
between NHL survivors who met and did not meet recommended public-health exercise 
guidelines of at least 150 minutes per week of moderate to strenuous activity (Vallance, 
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Corneya, Jones, & Reiman, 2005). The NHL survivors who met these guidelines reported 
higher QOL than those who did not meet them, suggesting that individuals who exercise at 
least 150 minutes per week receive physical and mental health benefits (Pate et al, 1995). 
Bellizzi et al (2009) also explored physical activity as it related to QOL and found that 
survivors who engaged in some form of physical activity reported better physical and mental 
health (p < .001). Furthermore, Reeve et al. (2009) examined QOL among older adults using 
the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey in a 
longitudinal, population-based study. Changes in QOL from before and after the cancer 
diagnoses were reported for nine cancer types including NHL. The NHL survivors (n = 53) 
had one of the highest declines in physical health.  
 In summary, these studies highlight that older adult cancer survivors and those with 
comorbid illnesses experience more physical health problems and worse physical QOL 
compared to their younger counterparts and healthy controls. However, physical activity can 
provide some protective effects and improve QOL for these individuals.  
Psychological Well-Being  
 Psychological changes occur during the survivorship trajectory and can be stressful 
on the mind and body, resulting in negative health outcomes for the survivor. How an 
individual appraises his or her diagnosis or the perceived threat of the cancer can affect 
clinical and psychological outcomes (Tedeschi, Park, & Calhoun, 1998). In addition, the 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition recognizes that a cancer 
diagnosis meets the criteria of a traumatic stressor (American Psychiatric Association, 2000). 
For example, survivors of NHL may develop symptoms of post-traumatic stress disorder 
(PTSD) that are also reported in individuals who experience a non-cancer-related traumatic 
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event (e.g., motor vehicle accident, sexual assault, military combat; Geffen et al., 2003; 
Smith et al., 2008) .  
 In a cross-sectional study of 886 NHL survivors, 8% met the criteria for a full PTSD 
diagnosis (compared to an estimated 2.4% prevalence in the general adult population), 9.1% 
met partial criteria, and 39.0% of the total sample had PTSD symptoms in at least one of the 
three domains used for diagnosis (Smith et al., 2008). In addition, Geffen, Blaustein, Amir, 
and Cohen (2003) found that NHL survivors who had more PTSD symptoms also 
experienced lower physical QOL.  
 In other studies, lymphoma survivors were found to have mental health functioning 
comparable to the general population (Bellizzi et al., 2009). However, survivors with active 
NHL disease had worse mental health functioning than those individuals in remission. In 
addition, younger NHL survivors (25–34 and 45–55 years of age) had lower mental summary 
scores than the general population (Smith et al., 2009). In summary, it has been shown that a 
cancer diagnosis affects an individual’s psychological well-being and their ability to cope 
during a time of uncertainty.  
Social Well-Being  
 Social well-being encompasses the interpersonal relationships that may have been 
changed by the cancer experience as the survivor reintegrates into the social environment. 
Aside from receiving the diagnosis, the treatment for NHL can have a negative effect on 
various QOL domains, including changes in social relationship. Social functioning after a 
cancer diagnosis may be a long-term adjustment for many survivors.  
 In one study, Bellizzi et al. (2009) reported that NHL had a positive effect on 
relationships but a negative effect on a survivor’s current financial situation. The social 
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impact of financial and relationship changes led survivors to other sources of social support. 
Social support was a significant positive psychosocial variable with a mean of 83.1 (SD 16.4) 
on a 20–100 scale. This number indicates that NHL survivors have supportive resources or 
individuals that are important to them during a time of unpredictability (Smith et al., 2009). 
These financial and relationship changes led survivors to individuals who were important to 
them during a time of unpredictability and change (Smith et al., 2009). Employment, 
financial, and insurance issues are also ongoing concerns of survivors and will be addressed 
in the functional well-being section.  
Functional Well-Being 
 The Functional Assessment of Cancer Therapy-General (FACT-G) measure includes 
functional well-being as one of its QOL domains. Six of the studies used the FACT-G 
instrument with consistent findings that one or more health problems coupled with NHL can 
lead to a decline in functional well-being. Chronic conditions can impede a survivors’ ability 
to maintain healthy behaviors and lifestyles, further contributing to a decline in function. 
Hewitt et al. (2003) reported that cancer survivors, including those of NHL, have almost a 
twofold likelier chance of having at least one functional limitation than the average populace. 
When an additional chronic condition is combined with cancer, functional limitation 
increases. In addition, Diamond, Taylor, and Anton-Culver (2010) reported that HIV-infected 
survivors with NHL have worse overall QOL and survival rates than uninfected survivors 
with NHL, indicating that having more than one life-limiting illness had a detrimental effect 
on the overall health and survival of their study participants.  
 Smith, Zimmerman, Williams, and Zebrack (2009) reported that 60% of NHL 
survivors were either unemployed or retired due to cancer-related issues. In addition, how 
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NHL survivors perceive their illness can influence their functional and physical abilities, 
which can impede their QOL (Smith, Crespi, Petersen, Zimmerman, & Ganz, 2010). 
Functional change at any juncture of the survivorship journey may require a change in living 
arrangements and the amount of support needed. This QOL domain continues to gain more 
interest as the population ages and that has related impacts on daily living.  
 In one study, survivors who maintained their work status reported higher physical 
QOL compared to those who reduced their work hours or stopped working completely (Mols, 
Thong, Vreugdenhil & van de Poll-Franse, 2009). 
. Forty-one percent of the participants in the same study reported a change in work status and 
related QOL decline due to their cancer, along with problems obtaining insurance or a 
mortgage.  
 Not only do NHL survivors experience physiological effects with risks of disability 
and poor functioning, but they also have psychological stresses on their QOL associated with 
healthcare expenditures. In addition, individuals with chronic health conditions, including 
cancer survivors, account for the majority of U.S. healthcare expenses. The assessment of 
QOL may direct interventions that reduce healthcare costs and, ultimately, improve QOL 
(Baker, Haffer, & Denniston, 2003).  
Spiritual and Existential Well-Being 
 Cancer survivors’ experiences parallel those individuals who have experienced other 
traumatic stressors involving acute, unpredictable events that threaten an individual’s life. 
However, few studies have assessed the positive psychological changes or benefits from the 
illness (Bellizzi et al., 2009; Tomich & Helgeson, 2004). In one of these studies, the majority 
of cancer survivors reported that experiencing a traumatic event, such as the diagnosis of a 
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life-threatening illness, led to positive personal changes, a greater ability to cope with life 
stressors, and a sense of personal strength (Tedeschi et al., 1998). Post-traumatic growth is an 
interrelated concept that has been linked with the spiritual and existential QOL domain, or a 
“perceived positive psychological change experienced as a result of the struggle with highly 
challenging life circumstances” (Stanton, Bower, & Low, 2006). Exploration of the role of 
spirituality has increased in recent years but is typically not addressed or described in 
research studies.  
 In addition, having cancer often prompts individuals to revisit their outlook on life. 
Zebrack’s (2000) study used a qualitative approach with face-to-face, semistructured 
interviews to explore four QOL domains (physical, psychological, social, and 
spiritual/existential). The spiritual/existential QOL domain was reflected in finding purpose 
and meaning in life, which were critical components in the survivorship trajectory. Zebrack 
(2000) found that having a purpose in life and hopefulness were highly scored spiritual 
subscale items, leading to a conclusion that survivors who were hopeful had better QOL.  
Treatment Effects on Quality of Life 
 Watch-and-wait or active surveillance approaches for indolent types of NHL are the 
most conservative management strategies. Surveillance involves monitoring through blood 
tests and physical examinations until the symptoms progress or the cancer interferes with the 
survivor’s QOL (Bailey, Mishel, & Belyea, 2004). Individuals with fast-growing or 
aggressive NHL often present with symptoms such as fatigue, weight loss, night sweats, or 
complaint of sore lymph nodes (Elphee, 2008). Aggressive NHL is commonly treated with 
targeted biologic therapies such as rituximab.  
 Most NHL survivors included in these studies received chemotherapy, radiation 
therapy, rituximab, or some combination of them for their treatment. The NHL survivors 
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treated with chemotherapy or with active disease reported significantly worse psychological 
and social well-being and health-related QOL than those who had not received chemotherapy 
(Diamond et al., 2010; Stanton et al., 2006). The survivors who reported significantly less 
vitality and worse general health compared with the general population (Reeve et al., 2009; 
Mols et al , 2007), and those treated with either radiation therapy or watchful waiting did not 
report a worse QOL compared with the general population (Bailey et al., 2004). Survivors 
who relapsed had worse QOL and physical and mental functioning compared to newly 
diagnosed NHL survivors (Pettengell, Donatti, & Hoskin, 2008).  
 Persson and Hallberg (2004) explored the experience of receiving lymphoma and 
leukemia treatment using a phenomenological design. Three themes emerged from their 
research about what survivors experienced while undergoing treatment: belief in life (they 
fought for it and came through stronger); life went on (they adapted and found a balance in 
the new life); or life was over (they felt out of control and lost belief in life). The impact of 
the disease varied depending on the survivors’ illness trajectory and their ability to cope with 
the disease’s unpredictability. This study supplied meaning to the experiences felt by  
lymphoma and leukemia survivors and allowed them to retell their stories of living with their 
disease.  
Older Adults with NHL 
 Age-related issues that impact QOL for NHL survivors were examined in less than 
ten studies. For those that did, older age was associated with worse physical QOL but better 
mental health compared with younger NHL adults (Mols, Coebergh et al., 2007; Smith et al., 
2009; Reeve et al., 2009, Zebrack, 2000; Mols, Aaronson et al., 2007; Arora et al, 2007; 
Kouroukis, Meyer, Benger, Marcellus, Foley, & Browman, 2004).  
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Most of the survivors studied received chemotherapy in combination with radiation therapy, 
surgery, bone marrow transplant, stem cell transplant, or biological therapies. Additionally, 
older survivors who received chemotherapy had poorer psychological and social well-being 
compared to those who did not receive chemotherapy (Mols, Coebergh et al., 2007; Mols et 
al., 2009). 
  It is not uncommon that older adults have one or more coexisting illnesses coupled 
with cancer (Yancik et al., 1996), so that is a finding that needs to be explored. Further 
research within this population will provide new insights into how older NHL survivors 
manage their multiple comorbidities and their impacts on their QOL.  
Design and Framework  
 The design and framework of a study impacts the quality of the data and how it 
relates to other areas of research. The methods used in the reviewed studies (Table 2.1) had 
both negative and positive effects on the ability to use the data as an accurate measurement of 
the QOL in NHL survivors. Large, cross-sectional studies are generally less costly than 
longitudinal studies but are limited to describing only associations within the sample. For 
example, cross-sectional designs do not answer cause and effect questions but provide useful 
information in the exploration of relationships among QOL domains and the effects of cancer 
treatments.  
The lack of a conceptual or theoretical model can be problematic when QOL is used 
to guide the study’s design or is viewed as the outcome variable. While theoretically driven 
studies allow relationships to be tested in the model, only three reviewed studies identified 
conceptual or theoretical perspectives (Smith et al., 2008; Smith et al., 2009; Arora et al., 
2007). Inclusion of a model addressing the multidimensionality of QOL and its 
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interrelationships or factors among QOL domains allows for hypotheses and relationships to 
be tested (Aaronson, Meyerowitz, & Bard, 1991). Using theoretically based models of QOL 
increases applicability of the concept and contributes to the ongoing development of cancer 
survivorship models. Ultimately, intervention studies to improve QOL in NHL survivors 
could be developed based on these models. 
Discussion 
 This paper provides an integrative review of the NHL survivorship literature relevant 
to older NHL survivors with a focus on the QOL measures and treatment methods used. 
While a limited number of studies examining QOL factors of older NHL survivors were 
found, the literature reflected growing interest in understanding the QOL among NHL 
survivors as a group. This is evidenced by recently published research (within the last 
decade) from around the world. Limitations of this literature review include 
underrepresentation of minority NHL survivors, lack of longitudinal studies and theoretical 
or conceptual frameworks, limited findings specific to older adults, and lack of literature 
regarding long-term survivors. In other cancer groups, racial, ethnic, or both types of 
differences in QOL have been reported; therefore, future NHL studies with increased 
minority representation may find similar disparities (Chlebowski et al., 2005). Also, 
qualitative studies are needed to enhance the understanding of the impact that NHL has on 
QOL for survivors, particularly in minority and older populations. Finally, mixed-methods 
studies that complement quantitative findings and explore the experiences of NHL survivors, 
such as Zebrack et al.’s (2008) study in which survivors shared their experiences of receiving 
their cancer diagnoses and their uncertainties about the future associated with decreased 
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QOL, would be beneficial. It is one example of how quantitative and qualitative methods 
inform each other, at least in the spiritual and existential domain of QOL.  
 Although QOL was measured objectively in all the studies, it is important to 
understand the subjective nature of QOL’s multidimensionality that allows survivors to 
express their experiences more thoroughly. Using qualitative methods to complement 
standardized QOL-related instruments would more adequately capture the totality of a 
survivor’s experience compared to using one measure.  
 Implications for Future Research  
 Cancer survivors are at increased risk for QOL-related concerns due to their exposure 
to disease and treatment-related effects (e.g., recurrences, secondary malignancies, 
cardiotoxicities, social and financial issues) compared to the general population (Ganz, 
2001). Lack of understanding of the QOL outcomes (i.e., physical, psychological, social, 
functional, and spiritual and existential outcomes) of older adults with cancer is a growing 
health concern due to the aging U.S. population. For survivors of all ages, there is increasing 
information on intermediate (2–5 years postdiagnosis) and longer term (> 5 years 
postdiagnosis) adjustment to NHL. Increasing sociodemographic diversity in the sample 
could also enhance generalizability of the findings. 
 As the growing population of older NHL survivors increases, research focused on 
QOL-related outcomes is needed. Future studies are needed to build on descriptive, cross-
sectional designs and provide a more comprehensive understanding of the survivorship 
journey. Longitudinal designs in cancer survivorship research can help specify under what 
circumstances the process of cancer survivorship adaptation is best described (Aziz & 
Rowland, 2003). From these longitudinal findings, interventions tailored specifically to NHL 
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survivors will determine who responds to the intervention and the sustainable effect of the 
intervention. Study findings could be generalized also to a larger, long-term, survivor 
population.  
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CHAPTER 3 
 
AN EXPLORATORY MEDIATION MODEL OF THE RELATIONSHIPS 
BETWEEN POSITIVE AND NEGATIVE ADAPTATION TO CANCER AND NHL 
SURVIVORS’ QUALITY OF LIFE 
 
 
Introduction 
 The Institute of Medicine (2006) and the National Cancer Institute (NCI) have 
redefined cancer survivorship to include the multifaceted and interrelated “physical, 
psychosocial, and economic issues of cancer from diagnosis until the end of life” (NCI, 
2008). However, this new definition does not account for the varied and unique experiences 
of each person that culminate in their non-Hodgkin lymphoma (NHL) survivorship 
trajectories. The increase in survivorship numbers has generated interest not only in 
exploring their long-term impact on quality of life (QOL), but also on factors that influence 
survivors’ adaptation to living with the disease. 
 There is accumulating evidence indicating that NHL survivors’ QOL varies; some 
report positive outcomes from their diagnoses and treatments, and others experience negative 
outcomes including poor health and poor QOL (Arden-Close, Pacey, & Eiser, 2010; Bellizzi, 
Miller, Arora, & Rowland, 2007; Mols et al., 2007; Reeve et al., 2009). Researchers have 
suggested that the psychosocial domains of survivorship—such as affect, mood, and QOL 
including spiritual, social, and emotional well-being—are among the most important 
outcomes for NHL survivors, if we are to extend our understanding of survivorship to 
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include QOL for NHL survivors (Cella et al., 1993; Ferrell, Dow, Leigh, Ly, & Gulasekaram, 
1995; Ferrell, Dow, & Grant, 1995).  
 The literature has found that negative psychosocial well-being has an effect on QOL, 
but few studies have considered  the positive psychological changes and possible benefits of 
adaptation to the illness (Bellizzi et al., 2007; Tomich & Helgeson, 2004). Interestingly, the 
majority of cancer survivors in one study reported that experiencing a traumatic event, such 
as a diagnosis of a life-threatening illness, led to positive personal changes in their lives, a 
greater ability to cope with life stressors, and a sense of personal strength (Tedeschi, Park, & 
Calhoun, 1998). Cancer survivorship represents a turning point for many individuals and not 
one that is always negative to their overall QOL.  
 There is a growing body of NHL literature and additional studies are needed to 
explore how cancer survivors adapt to the disease. Physical functioning has been the primary 
QOL outcome measured in NHL survivors, and less focus has been given to psychosocial 
and emotional health (Leak, Mayer, & Smith, 2011). Understanding the positive and negative 
relationships that cancer and its treatments may have on the long-term health of NHL 
survivors is an important aspect of survivorship and overall QOL. A cancer diagnosis carries 
the possibility of disrupting life and can have varied QOL outcome implications. The purpose 
of this paper is to explore which personal and disease characteristics are associated with QOL 
and to investigate whether or not adaptation to living with cancer may mediate their effects. 
The research questions for this paper are: 
1. What demographic and disease characteristics are associated with QOL? 
2. How does adaptation to cancer mediate the relationship between demographic and 
disease characteristics and QOL?  
 49 
 
Conceptual Framework 
 The cancer survivor adaptation (CSA) model of QOL among NHL survivors was 
developed for this study and adapted from Naus, Ishler, Parrott, and Kovacs’ (2009) model. It 
has three components: personal characteristics, adaptation, and outcomes. Adaptation, the 
fundamental component of this model, is an ongoing, cognitive process involving continuous 
appraisal of the situation by the survivor (Naus et al., 2009). It is reflected as positive and 
negative adaptation. Positive adaptation has favorable psychosocial implications such as 
better coping skills. It encompasses these positive aspects: altruism and empathy, health 
awareness, understanding the meaning of cancer, and positive self-evaluation. Negative 
adaptation focuses on appearance concerns, body change concerns, life interferences, and 
worry. It has unfavorable physical or psychological outcomes (Zebrack, Ganz, Bernaards, 
Petersen, & Abraham, 2006). The Impact of Cancer (IOC) scale conceptualizes the cancer 
experience as perceptions. In this study we have conceptualized perceptions as adaptation.  
 The CSA model proposes that personal characteristics, which include demographic 
and disease factors, can have a direct positive or negative association with QOL. 
Relationships between personal characteristics and QOL outcomes can be mediated through 
positive or negative adaptation to the illness. Personal characteristics are represented by 
individual characteristics (demographic and disease factors), positive adaptation or negative 
adaptation, and outcomes of cancer-specific QOL (Figure 3.1).  
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Figure 3.1. The cancer survivor adaptation model illustrating the three components and three 
variables that affect the positive and negative adaptation of survivors to their cancer 
diagnoses and treatments. Source: Adapted from Naus, Ishler, Parrott, and Kovacs, 2009.  
 
Method 
Study Design 
 This research was a secondary analysis of a cross-sectional study of NHL survivors. 
The primary aim of the initial study was to estimate the prevalence of post-traumatic stress 
disorder (PTSD) symptoms in survivors of adult NHL who were at least two years post-
diagnosis and to identify risk factors associated with PTSD symptoms for the study 
population (Smith, Zimmerman, Williams, Preisser, & Clipp, 2008).  
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Participants and Procedures 
 The data were accrued through mailed surveys. Participants were NHL survivors 
treated at one of two comprehensive cancer centers in North Carolina: the Duke Cancer 
Center and the University of North Carolina at Chapel Hill’s Lineberger Comprehensive 
Cancer Center. Eligibility criteria for the parent study included an age of 18 years or older, at 
least 2 years postdiagnosis, and either currently receiving treatment, in remission, or cured. 
Survivors were defined as individuals postdiagnosis, whether or not they had active disease 
(National Coalition for Cancer Survivorship, n.d.). 
Measures  
 Demographic and disease characteristics. The sociodemographic information 
collected included current age, gender, income, education level, ethnicity, marital status, and 
employment status. The disease-related characteristics included total comorbidity score, 
cancer treatment(s) undergone (i.e., surgery, radiation therapy, chemotherapy, biologic 
therapy, bone marrow transplantation [BMT] and/or stem cell transplantation [SCT]), 
remission status, and years since diagnosis. The sociodemographic and disease-related 
characteristics were self-reported.  
 The self-administered Sangha comorbidity questionnaire (Sangha, Stucki, Liang, 
Fossel, & Katz, 2003) was used to assess past and current health conditions. The conditions 
listed were heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach 
disease, kidney disease, liver disease, anemia or other blood disease, cancer other than 
lymphoma or non-melanoma skin cancer, depression, osteoarthritis, degenerative arthritis, 
back pain, and rheumatoid arthritis. There were also two open-ended spaces for conditions 
that could be specified by the participant. The comorbidity score consisted of the sum of the 
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answers to three questions for each of the ten conditions: 1) whether the participant had ever 
been seen for the listed condition, 2) whether they were currently receiving treatment for the 
condition, and 3) whether their function was limited by the identified condition. A binary 
answer (yes-1 or no-0) was supplied for each question. The total comorbidity score ranged 
from 0 to 30 with higher scores indicating a greater comorbidity burden and lower scores 
indicating a lower burden.  
 Adaptation. The Impact of Cancer (IOC) Scale, version 2 (Zebrack, Ganz, 
Bernaards, Petersen, & Abraham, 2006), is a 37-item scale used to measure perceptions of 
positive and negative aspects of one’s life as they relate to cancer. For this study, the IOC 
was used to measure adaptation to living with cancer. The four positive subscales were 
altruism and empathy, health awareness, understanding of the meaning of cancer, and 
positive self-evaluation. The negative subscales were appearance concerns, body change 
concerns, life interferences, and worry. Higher scores overall on the positive subscales 
indicate a more positive adaptation, and higher scores on the negative subscale indicate a 
more negative adaptation. The reliabilities for all subscales are 0.90. 
 Quality of life outcomes. The 27-item Functional Assessment of Cancer Therapy-
General, version 4 (FACT-G; Cella et al., 1993), was used to measure general cancer–related 
QOL outcomes in physical, social and familial, emotional, and functional domains. The total 
FACT-G was used as the QOL outcome. Satisfactory reliability and validity for the FACT-G 
has been reported in initial psychometric studies (Cella et al., 1993; Cella, Webster, & Cashy, 
2005). The reliability of the FACT-G subscales and total score ranged from 0.77 to 0.93 in 
the initial study (Smith et al., 2008). 
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Data Analyses 
 Descriptive statistics were computed for the secondary study using the Statistical 
Package for the Social Sciences, version 14. Multiple regressions and SEM analyses were 
conducted using MPlus, version 4.2, to test the proposed model of demographic and disease 
characteristics, positive and negative adaptation, and QOL outcomes. Most variables had less 
than 5% missing data, but one variable was noted to have a higher percentage of missing 
data: the disease stage (13%). It was not statistically significant in the regression and SEM 
analyses and was therefore excluded. The adaptation and QOL variables were latent.  
 In conducting SEM, it is important to include variables and paths that are both 
supported mathematically and reflect theoretically meaningful relationships. A number of fit 
indices were used to assess model fit as suggested by the guidelines for SEM (Baron & 
Kenny, 1986). We used the goodness-of-fit index (GFI), comparative fit index (CFI), Tucker 
Lewis Index (TLI), and root mean square error of approximation (RMSEA). An adequate fit 
is indicated by values of 0.05 or smaller for the RMSEA and 0.90 or greater for the other 
indices, (Brown & Cudeck, 1993). The model was trimmed to remove non-significant paths, 
and standardized model coefficients were reported. The units of standardized coefficients for 
continuous correlates were standard deviations and are presented in Table 3.1. 
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Table 3.1 
Demographic Characteristics of the Sample  
Variable  All Survivors 
(N = 771)
 n % 
Demographics   
Gender   
 Male  384 49.8 
 Female  387 50.2 
Race   
 White  662 85.9 
 Minority 109 14.1 
Ethnicity    
 Hispanic 12 1.5 
 Non-Hispanic 759 98.5 
Education    
 College Graduate 314 59.3 
 Not a College  
 Graduate 
457 40.7 
Marital Status   
 Married/Living with  
Partner 
589 76.3 
 Not Married/Living  
 with Partner 
181 23.6 
 Missing 1 0.1 
Employment Status    
 Retired/Unemployed  437 56.7 
 Employed 322 41.8 
 Missing 12 1.5 
Income ($ annually)   
 < 30,000 213 27.7 
 30,000–59,999 236 30.6 
 60,000–89,999 136 17.6 
 90,000 or higher  186 24.1 
Disease Characteristics    
NHL Histology   
 Indolent  384 49.8 
 Aggressive 346 44.9 
 Missing  41 5.3 
Stage at Diagnosis   
 I 217 28.1 
 II 141 18.3 
 III 126 16.4 
 IV 189 24.5 
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 Missing  98 12.7 
Currently in Remission    
 Yes 602 78.1 
 No 98 12.7 
 Don’t Know 71 9.2 
Currently receiving  
treatment  
  
 Yes 107 13.8 
 No 664 86.2 
Treatments Received    
Chemotherapy  613 
369 
79.5 
47.8 Radiation Therapy 
Biologic Therapy  233 
231 
30.2 
29.9 Surgery 
Bone Marrow/Stem  
Cell Transplantation  
123 15.9 
Other Therapy 93 12.1 
Missing Age 
Average age  
20 
62 (13.5)  
 
0.2 
Range 24–92  
 
Note. Numbers given in parenthesis are standard deviations. 
Results 
Sample 
 There were 1,312 eligible NHL survivors, and 886 responded to the surveys, with a 
68% response rate (Smith et al., 2008). There were 771 survivors with complete data for the 
IOC and FACT-G. The demographics of this sample are given in Table 3.1.The average age 
at the time of study was 62.2 (SD 13.5, range 25–92). Over half of the participants were 
either retired or unemployed (53%), and 25% earned less than $30,000 annually. Fifteen 
percent were of racial backgrounds other than White. The participants were evenly split 
between genders, 50% female and 50% male. A majority of the sample reported having had 
chemotherapy (80%), and 48% had radiation as part of their treatment. More than half of the 
NHL survivors had never had a recurrence (59%). An even larger proportion of participants 
were self-reportedly in remission (78%). The mean years since diagnosis were 10.2 (SD 7.1). 
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For the disease characteristics of this sample, 32% of the participants had Stage I cancer and 
28% had Stage IV cancer. The mean total comorbidity score was 5.6 (SD 4.8; range 0–30) 
which indicates a high comorbidity burden.  
Demographic and Disease Characteristics’ Relationships with Quality of Life  
Research Question 1: What demographic and disease characteristics are associated with 
QOL? 
 Results. We conducted a multiple linear regression to model the QOL scores from the 
FACT-G and to identify the significant independent variables (all at p < .05) to address this 
research question. The bivariate associations between QOL and the independent variables are 
given in Table 3.2. The significant demographic characteristics in the multiple regression 
model were age, gender, education (college graduate vs. not a college graduate), annual 
income (< $30,000 vs. $30,000 +), and employment status (employed vs. not employed). 
Significant disease characteristics were total comorbidity scores, some treatment types (BMT 
or SCT, biologic therapy), and years since diagnosis.  
 
Table 3.2 
 
Mediation Model of Direct and Indirect Effects of Significant Characteristics on QOL with 
Standardized Coefficients  
 
Characteristics  Regressio
n Model 
TDE on 
QOL with 
mediators 
TDE on 
positive 
adaptatio
n 
TDE on 
negative 
adaptatio
n 
TIE on 
QOL 
via 
positive  
TIE on 
QOL via 
negative 
Total 
Effects 
Demographic   
Current age at 
study 
0.185 0.078 -0.114 -0.156 -0.034 0.134 0.178 
Female 0.079 - 0.126 - 0.037 -  
< $30,000 
annually  
-0.136 -0.123 - -   - 
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College 
graduate  
0.086 - -0.154 -0.152 -0.045 0.131  
Employed 0.090  - - - -  
Minority - - 0.217 0.098 0.064 -0.084  
Disease  
Comorbidity 
score 
-0.590 -0.164 - 0.340 - -0.292 0.456 
Remission 
status 
- - - 0.068 -   
Currently 
receiving 
treatment  
-0.110 - -0.150 0.125 -0.044 -0.107  
BMT/SCT -0.120 - - 0.202 - -0.174  
Biologic -0.081 - -  - - - 
Chemotherapy - - 0.196 0.113 0.058 -0.097 - 
Years since 
diagnosis 
0.098 -0.066 - -0.175 - 0.151 0.085 
Note: Positive adaptation and negative adaptation are the mediators. Variables that were not 
significant in the model were ethnicity, marital status, age at diagnosis, and certain cancer 
treatments including surgery and radiation therapy. BMT = bone marrow transplant, QOL = 
quality of life, SCT = stem cell transplantation, TDE = trimmed direct effects, TIE = trimmed 
direct effects. p < .05. 
 
 The model indicated that QOL was worse for survivors who were males, younger at 
the time of the study, had a greater comorbidity burden, had received a BMT or SCT or 
biologic therapy, or had been diagnosed more recently (all at p < .05). These significant 
variables were included in the final trimmed model and accounted for 34% of the variance in 
QOL. All coefficients in Table 3.2 were statistically significant. 
Research Question 2: How does adaptation to cancer mediate the relationship between 
demographic and disease characteristics of QOL?  
 Goodness-of-fit results. Before the full model was examined, measurement models 
were assessed to establish relationships among observed variables (indicators) and the three 
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latent variables (positive adaptation, negative adaptation, and QOL). The results per latent 
variables were (a) QOL using FACT-G (4 subscales): chi-square value (χ2) = 59.443, df = 2, 
CFI = 0.958, TLI = 0.873, RMSEA=0.181; (b) positive adaptation using IOC (4 subscales): 
χ2= 14.904, df = 2, CFI = 0.988, TLI = 0.964, RMSEA = 0.085; and (c) negative adaptation 
using IOC (4 subscales): χ2= 1.619, df = 2, CFI = 1.000, TLI = 1.001, RMSEA = 0.000. 
Higher loadings indicated a stronger relationship between the indicator and latent variables 
(Kline, 2005; Bollen, 1989). 
 The full hypothesized model included the observed and latent variables. The results 
indicated that the fit of the hypothesized model to the data was mixed and inadequate: χ2 = 
1091.690, df = 241, CFI = 0.824, TLI = 0.767, RMSEA = 0.069. The model was trimmed to 
remove extraneous variables and insignificant paths (Baron & Kenny, 1986). To ensure the 
most parsimonious model and to reduce the number of parameters to be estimated, only 
significant paths (p < .05) were included in the model (Kline, 2005). The paths insignificant 
to QOL were type of comorbidity problems, remission status, currently receiving treatment, 
most cancer treatments (surgery, radiation, chemotherapy, BMT or SCT, biologic, or other 
therapies), gender, ethnicity, employment income, education, race, and marital status. The 
paths insignificant to positive adaptation were type of comorbidity problems, remission 
status, most cancer treatments (surgery, radiation, BMT or SCT, biologic, or other therapies), 
being Hispanic, being employed, income levels, current ages, and marital statuses. The paths 
insignificant to negative adaptation were type of comorbidity problems, some cancer 
treatments (surgery, radiation, or other therapies), being female, being Hispanic, being 
employed, having an income equal to or greater than $30,000 annually, and marital status.  
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 The trimmed model was refit and then trimmed a second time due to two insignificant 
paths: gender to negative adaptation and income to negative adaptation. The remaining paths 
were all significant at the .05 level and were not deleted from the mediation model (Table 
3.2). This final mediated model had an adequate fit with the following GFIs: χ2= 1393.776, df 
=188, CFI = 0.775, TLI = 0.735, RMSEA = 0.091. An acceptable chi-square to degrees of 
freedom ratio is less than 3, and our study met this guideline (Byrne, 2001; Kline, 2005).  
 Partial and full mediation results. The mediation models allowed for the 
examination of potential intervening variables that linked an independent variable to a 
dependent variable. A direct effect, unmediated, is a path from one of the model variables to 
the outcome variable of QOL. Positive adaptation had a direct positive effect and negative 
adaptation had a direct negative effect on QOL. There were direct effects from four personal 
characteristics on QOL: income, current age, total comorbidity score, and years since 
diagnosis. Income’s direct effect on QOL was the only effect it had, so the relationship 
between income and QOL was unmediated.  
 The other three effects were partially mediated by either negative adaptation 
(comorbidity burden, years since diagnosis) or both negative adaptation and positive 
adaptation (current age). The remaining personal characteristics had no direct effects on 
QOL, but they had fully mediated effects through negative adaptation (BMT or SCT), 
positive adaptation (gender), or both (education and current treatment status).  
 The effect of current age on QOL was partially mediated by both negative adaptation 
and positive adaptation. Increased age was directly associated with increased QOL and a 
decrease in both positive adaptation and negative adaptation. The largest effect was the 
indirect effect via negative adaptation. The total effect (direct and indirect effects combined) 
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indicated that a 1-point SD increase in age directly predicted a 0.178-point increase in QOL, 
which was significant.  
 Total comorbidity scores and years since diagnosis had both direct effects and 
indirect effects mediated through negative adaptation on QOL. As the comorbidity burden 
increased, negative adaptation also increased and QOL decreased. For comorbidities’ effects 
on QOL, 36% were direct and 64% were indirect and mediated through negative adaptation. 
The total effect of a greater comorbidity burden on QOL was 0.456 points. A 1-point 
standard deviation increase in the total comorbidity score directly predicted a 0.164-point 
decrease in QOL.  
 The direct effect on QOL of the number of years since diagnosis was negative. 
However, this effect was partially mediated, because an increase in years since diagnosis was 
associated with lower negative adaptation scores, and thus an increase in QOL. The indirect 
effect was greater, and thus, the total effect on QOL of years post-diagnosis was positive. A 
1-point standard deviation increase of years since diagnosis directly predicted a 0.066-point 
increase in QOL, a significant finding.  
 The effect of having a BMT or SCT was fully mediated by negative 
adaptation, which was associated with lower QOL. Gender was mediated through 
positive adaptation; females were better able to positively adapt and had better QOL 
than males. Not being white and having received chemotherapy were also fully 
mediated through positive and negative adaptation. However, the total effects for both 
indicators were not significant (p > .05). The effects of being a college graduate and 
currently receiving treatment were indirect on positive and negative adaptation and on 
QOL. Thus, being a college graduate had indirect positive and negative effects with 
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increased and decreased QOL overlapping. This coexistence was also true for those 
currently receiving treatment, showing positive and negative indirect effects on QOL.  
Discussion 
 In this study, demographic and disease characteristics associated with the QOL of 
NHL survivors were explored using multiple regression and SEM techniques. At the 
bivariate level, several of the demographic and disease characteristics were strongly 
associated with QOL: current age, being a male, having an annual income of less than 
$30,000, having less than a college education, being unemployed or retired, having more of a 
comorbidity burden, currently receiving treatment, ever having received a BMT, SCT, or 
biologic therapy, and the number of years post-diagnosis. These findings are consistent with 
prior studies that reported statistically significant associations of sociodemographic variables 
with QOL outcomes for breast and lymphoma cancers (Kornblith et al., 2003; Geffen, 
Blaustein, Amir, & Cohen, 2003; Zebrack et al., 2006; Bellizzi & Blank, 2006). These results 
indicate that adaptation to positive and negative aspects of cancer can help explain the 
relationship of these characteristics to QOL.  
 These findings support and extend the current NHL literature and the CSA model. 
Bellizzi et al. (2007) found that 78% of NHL survivors reported at least one positive and one 
negative change in their lives related to their cancer experience. This study’s results indicate 
that positive and negative adaptation was common, but especially negative adaptation. 
Current age at time of study was a significant indicator and accounted for the only partial 
mediation. Older adults (> 65 years of age) were less likely to report negative changes 
compared to younger survivors (< 65 years of age), and this is similar to previous findings 
(Bower et al, 2005; Blank & Bellizzi, 2006). This suggests that older adults have experienced 
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other significant life events or stressors and have learned how to manage these life changes, 
unlike younger survivors.  
 Younger survivors at the time of the study, survivors with a higher comorbidity score, 
unemployed or retired survivors, and survivors with fewer years passed since the time of 
their diagnoses had a more difficult time adapting to the cancer experience. Life interferences 
and worry may also have negative associations with abrupt changes in work and family 
environments, leading to economic constraints, so it is possible that the demographic factors 
were interrelated. Positive and negative adaptation co-occurred, which supports the notion 
that survivors continually appraise their cancer experience and adjust to various factors 
associated with increased or decreased QOL.  
 Survivors with less than a college education experienced both positive and negative 
changes, a finding supported by previous findings on the relationship between negative life 
changes and adaptation with lower education (Cordova, Cunningham, Carlson, & 
Andrykowski, 2001; Sears, Stanton, Danoff-Burg, 2003). Additionally, NHL survivors with a 
relatively recent diagnosis (2–5 years postdiagnosis) need to be targeted for help adjusting to 
the ongoing, dynamic process of adaptation. Equipping this population with information and 
resources early will emphasize not only the positive changes adaptation may bring but give 
them ways to overcome the negative effects of the cancer experience. Hopefully, with early 
intervention, their cognitive appraisal processes will change faster as stressors and 
psychological growth occur, reflecting integration into a new way of life (Conway, 2005; 
Conway, Meares, & Standart, 2004; Conway & Pleydell-Pearce, 2000). The CSA model 
shows that QOL changes occur differently in each QOL domain, which may aid newly 
diagnosed survivors in recognizing that positive and negative coping behaviors are expected 
 63 
 
to occur. It is hoped that this understanding will help them reintegrate into their social 
environments.  
 The SEM model found that current age, being a male, having less than a college 
degree, being non-White, currently receiving treatment, and having received chemotherapy 
had direct associations with positive adaptation and higher levels of reported QOL. Current 
age, not being a college graduate, being a minority, having a greater comorbidity burden, 
being in remission, currently receiving treatment, having received a BMT, SCT, or 
chemotherapy, and years since diagnosis had negative associations with adaptation and lower 
levels of QOL. Using SEM to test multiple relationships simultaneously offered a more 
thorough assessment than univariate analyses would. Thus, the model incorporated indirect 
and direct effects of demographic and disease characteristics, providing a basis for 
hypothesizing specific relationships among these variables.  
Limitations 
  Although the study gave important insight into the QOL of NHL survivors and their 
adaptations to cancer, there are some limitations to consider. This study was a cross-
sectional, secondary analysis and thus was limited in determining casual processes and 
relationships among factors. Because it used a secondary data set, items available for 
analyses were limited. Social support was available in the parent data set, but was not 
included in the secondary analysis. Inclusion of this variable might potentially increase the 
GFI for a stronger model fit. Future studies should investigate informal and formal social 
support sources (e.g., spiritual or existential beliefs, familial support) to investigate their 
associations with the QOL of NHL survivors. This analysis provided suggestions for causal 
models, but longitudinal research is needed to delineate the processes that link personal and 
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disease characteristics, adaptation to cancer, and QOL. Longitudinal research will also allow 
assessment of varying adaptation patterns over time and of how to intervene at the most 
critical points of the survivorship trajectory.  
 The results may not be generalizable to other cancers than NHL or to geographical 
locations. The data was self-reported with recall bias a concern. Based on the results of the 
goodness-of-fit indices, the initially hypothesized model had a better fit than the trimmed 
model. These findings were not expected and further analyses to determine adequate fit is 
needed. The model could be improved by measuring QOL with measures other than the 
FACT-G. The social and familial well-being subscale was weakly associated with the 
indicators when compared with the three other well-being subscales and that may have 
decreased the goodness of fit. Additionally, the model could be improved by including 
theorized relationships in the model that might not be significant to determine if the overall 
fit improves based on the theory, not just statistical analyses.  
Strengths 
 A strength of this study is the development of a conceptual model of indicators that 
incorporate demographic and disease characteristics, QOL factors, and adaptation. The 
conceptual CSA model identified theoretically meaningful relationships among the factors, 
and its final state incorporating the study’s results can be seen in Figure 3.2. It is clinically 
relevant and encourages clinicians to ask NHL survivors about adjusting to living with 
cancer and the coping process to provide resources to them throughout the survivorship 
period. Another strength of the study is the large sample size of a cancer-specific population 
in a diverse state. The observed squared multiple correlations between the latent variables 
indicates that they accounted for a substantial proportion of the variance in QOL. This study 
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also supported the idea that negative adaptation to cancer is associated with decreased QOL 
and potentially negative health outcomes (Bellizzi et al., 2007).  
 
 
Figure 3.2. Final model of cancer survivorship adaptation and quality of life with 
standardized paths estimates (N = 771). 
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 In summary, both positive and negative adaptation had significant path coefficients 
that showed mediation of the relationships between demographic and disease characteristics 
and QOL. These data illustrate the usefulness of the IOC as a general cancer-specific 
measure of adaptation and shows evidence of the need for intervention work with this 
population. Given the analysis from the mediation models, a negative perception of cancer is 
a stronger mediator than positive adaptation. Interventions tailored to assist survivors’ in 
cognitively reframing their experiences may be useful and may result in decreased adverse 
health outcomes and increased QOL.  
Conclusion 
 The CSA model was tested using SEM. Significant theorized relationships were 
supported by the data. Positive and negative adaptation mediated some effects of 
demographic and disease characteristics on QOL. Further research is needed to expand how 
positive and negative adaptation to cancer can have overlapping effects on the survivor and 
also on the caregivers and families of survivors. Interventions are needed to target support to 
NHL survivors postdiagnosis to improve their ability to reduce the negative effects of cancer 
and to support them in seeing the positive changes and benefits of living with the disease. 
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CHAPTER 4 
 
THE INFLUENCE OF AGE ON NON-HODGKIN LYMPHOMA SURVIVORS’ 
QUALITY OF LIFE 
 
 
Introduction 
 
 There are nearly 12 million cancer survivors in the United States, and this number 
rises as older adults live longer with the disease (National Cancer Institute [NCI], 2011). Not 
only are survivors living longer with the disease, they are managing other health conditions. 
The Institute of Medicine (IOM) report, Ensuring Quality Cancer Care, states that in caring 
for survivors with cancer, adequate measures should be taken to also address noncancer 
diseases in concert with the primary disease (Hewitt & Simone, 1999; Ko & Chaudhry, 
2002). These noncancer diseases are known as comorbidities, the coexistence of various 
chronic illnesses, which is an increasing health problem due to the rising proportion of older 
adults. Survivors with comorbidities present a challenge for cancer management. With an 
aging American population, the needs of older adults with cancer and comorbidities will 
become a dominant public health concern. Likewise, most cancers occur primarily in older 
adults (Yancik & Reis, 2000). Age and comorbidities are positively correlated; increasing 
age is associated with poorer physical health but higher levels of psychological health. 
Survivors with comorbidities have poorer physical and psychological QOL (Fortin et al., 
2006; Karakiewicz et al., 2008; Yancik, Ganz, Varricchio, & Conley, 2001). 
 Non-Hodgkin lymphoma (NHL) is the sixth most common cancer in the United 
States with more than 65,540 new diagnoses expected in 2011. As a person ages, their 
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likelihood of getting cancer increases. The survival rate for NHL survivors has increased, but 
it remains an illness that elicits concerns related to late- and long-term effects. Previous 
studies support that age differences affect quality of life (QOL) for breast cancer survivors, 
and they strongly suggest that younger breast cancer survivors (< 40 years of age) fare worse 
than their older counterparts in social functioning (Avis, Smith, McGraw, Smith, Petronis, & 
Carver, 2005; Ganz, Guadagnoli, Landrum, Lash, Rakowski, & Silliman, 2003; Kroenke, 
Rosner, Chen, Kawachi, Colditz, & Holmes, 2004). This trend has been mixed, however, 
because younger breast cancer survivors (< 50 years of age) reported significantly lower 
social functioning than their older counterparts in one study (Abrandt et al., 2004) and no 
significant age differences were found in another study (Ganz, Rowland, Desmond, 
Meyerowitz, & Wyatt, 1998). These findings provide a foundation for exploring the role of 
age in cancer survivors’ QOL, specifically in other populations such as NHL survivors. 
 A review of the literature showed that defining QOL is challenging at best. It is a 
widely accepted outcome measure that strives to balance the efficacy of possible treatment 
modalities with potential side effects and benefits to the survivors’ well-being. It is a 
subjective, multidimensional construct of an individual’s perception of specific goals, 
expectations, and values within the domains of physical, social and familial, emotional, and 
functional well-being (Ferrell, Dow, Leigh, Ly, & Gulasekaram, 1995; Parsons & Mayer, 
2004).  
 Moderators are independent variables that affect the direction of the association 
between another independent variable and the outcome variable and help to determine when 
the relationship occurs (Bennett, 2000). They are also described as influencing the strength of 
the relationship between two other variables. It is important to understand how age is 
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associated with QOL, and although there is evidence that personal characteristics are 
important in determining QOL, it is limited in the NHL survivorship literature. Thus, the 
moderator of age and its relationship with QOL will be explored in this paper. Understanding 
moderators that may interfere with, enable, reinforce, or facilitate a higher QOL during 
survivorship is critical for adults diagnosed with NHL. Therefore, the purpose of this study 
was to answer the following research question: 
1. Does age moderate relationships between demographic and disease 
characteristics and QOL for NHL survivors? 
Conceptual Framework 
 A cancer survivor adaptation (CSA) model of QOL among NHL survivors was used 
and adapted from Naus, Ishler, Parrott, and Kovacs (2009). It is described in Figure 4.1. It 
has three components: personal characteristics, a moderator (age), and outcomes. The model 
proposes that personal characteristics (demographic and disease factors) have a relationship 
with QOL and that there is potential that age may affect that relationship or its strength. 
Moderation is an important consideration in this study because the demographic variables 
and disease factors could potentially change the associations with QOL. The outcome 
variable for this model is QOL.  
Method 
Study Design  
 This research was a secondary analysis of a cross-sectional study of NHL survivors. 
The primary aim of the parent study was to estimate the prevalence of post-traumatic stress 
disorder (PTSD) symptoms in survivors of adult NHL who were at least two years 
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postdiagnosis and to identify the risk factors associated with PTSD symptoms (Smith, 
Zimmerman, Williams, Preisser, & Clipp, 2008).  
Participants and Procedures 
 The sample, during 2005 to 2006, was accrued through mailed surveys to individuals 
who were treated for NHL at one of two comprehensive cancer centers in the southeastern 
United States: the Duke Cancer Center and the University of North Carolina at Chapel Hill 
Lineberger Cancer Center. Eligibility included individuals 18 years of age or older, at least 
two years postdiagnosis, and with active disease. Survivors are defined as individuals from 
the time of diagnosis through the balance of their lives, and in this study, survivors with or 
without active disease (National Coalition for Cancer Survivorship,  n.d.) were eligible. This 
study was exempted as a secondary data analysis by the University of North Carolina at 
Chapel Hill’s Institutional Review Board. 
Measures  
 Demographic and disease characteristics. Sociodemographic information included 
current age, gender, income, education, ethnicity, and marital status. Disease-related 
characteristics included NHL histology, cancer treatments such as surgery, radiation therapy, 
chemotherapy, biologic therapy, and bone marrow or stem cell transplantation. The 
sociodemographic and disease-related characteristics were self-reported.  
 The self-administered Sangha comorbidity questionnaire (Sangha, Stucki, Liang, 
Fossel, & Katz, 2003) was used to assess past and current health conditions. The conditions 
listed were heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach 
disease, kidney disease, liver disease, anemia or other blood disease, cancer other than 
lymphoma or nonmelanoma skin cancer, depression, osteoarthritis, degenerative arthritis, 
 74 
 
back pain, and rheumatoid arthritis. There were also two open-ended spaces for conditions 
that could be specified by the participant. The comorbidity score consisted of the sum of the 
answers to three questions for each of the ten conditions: 1) whether the participant had ever 
been seen for the listed condition, 2) whether they were currently receiving treatment for the 
condition, and 3) whether their function was limited by the identified condition. A binary 
answer (yes-1 or no-0) was supplied for each question. The total comorbidity score ranged 
from 0 to 30 with higher scores indicating a greater comorbidity burden and lower scores 
indicating a lower burden. 
 Quality of life outcome. The 27-item Functional Assessment of Cancer Therapy-
General (FACT-G, version 4; Cella et al, 1993, was used to measure cancer-related QOL in 
physical, social and familial, emotional, and functional domains. In this study, the total score 
from the FACT-G was used as the QOL outcome. A higher score indicates a higher 
perception of QOL. Evidence of satisfactory reliability and validity for the FACT-G has been 
reported in initial psychometric studies (Cella et al, 1993; Cella et al, 2005). The reliability of 
the FACT-G subscales and total score ranged from 0.77 to 0.93 in the initial study (Smith et 
al, 2008). 
Data Analyses 
  Descriptive statistics were computed using SPSS. This study used multiple 
regression to analyze relationships between personal characteristics and QOL. The base 
model includes demographic and disease characteristics that were found to be statistically 
significant (all at p<.05) in another paper (Leak, Mayer, & Smith, 2011). The regression 
model was trimmed of all non-significant (p>.05) predictors before adding any interactions to 
test moderation of the effects by age (column 1 for Table 2), then each moderation effect was 
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tested separately. Interactions that were significant were jointly entered in the model, and the 
final model retained only those predictors that were significant (p<.05). All variables had 
<5% missing data except for cancer stage (13%) and was therefore excluded from the 
analyses.  
Results 
Sample 
 The study sample included 741 NHL survivors who were, on average, 62.3 (SD 13.4) 
years of age at the time of study (range 25–92). The demographics of the sample can be seen 
on Table 4.1. More than 40% of the sample were adults over 65 years of age (n = 322), and 
86% were Caucasian. Over half (58%) were either retired or unemployed, and 28% earned 
less than $30,000 annually. The mean time since diagnosis for the sample was 10.2 years (SD 
7.1). Disease characteristics for the sample included 28% of survivors in Stage 1 or 24% in 
Stage 4. A majority of the sample reported having had chemotherapy (80%) and radiation 
(48%) as part of their treatment. The total comorbidity score was 5.6 (SD 4.8) with a higher 
number indicating more comorbidity burden (range 0–30). On average, the number of 
comorbid problems for the entire sample was 2.90 (SD 2.1) but higher for older adults with a 
mean of 3.54 (SD 2.1). The most commonly reported comorbid problems were heart disease 
(18.7%), high blood pressure (18.2%), diabetes (14.1%), and lung disease (17.1%). Of the 
741 NHL survivors, 11.4% had no comorbidities, 18.7% had 1comorbidity, 18.2% had 2 
comorbidities, and 51.5% had 3 or more comorbidities. The younger survivors were more 
likely to be of a minority race, college-educated, married or living with a partner, and 
employed. The younger survivors also had higher annual income than the older survivors. 
 
 76 
 
Table 4.1 
Demographics of the Sample 
Variable  All 
Survivors  
(N = 741)  
Total 
% 
< 65 
years of 
age (n = 
419) 
Total 
% 
> 65 
years of 
age 
(n = 
322)  
Total 
% 
p value 
Personal Characteristics   
Gender        
 Male  377 50.9 220 52.5 157 48.8 .312 
 Female  364 49.1 199 47.5 165 51.2 
Race        
 White 640 86.4 347 82.8 293 91.0 .013 
 Minority 101 13.6 72 17.2 29 9.0 
Ethnicity         
 Hispanic 12 1.6 10 2.4 2 0.6 .059 
 Non-Hispanic 729 98.4 409 97.6 320 99.4 
Education         
 College Graduate 309 41.7 197 47.0 112 34.8 .000 
 Not a College  
 Graduate 
432 58.3 222 53.0 210 65.2 
 Marital Status        
 Married/Living with  
 Partner 
56 76.7 328 78.3 240 74.5 .000 
 Not Married/Living  
 with Partner 
172 23.2 91 21.7 81 25.2 
 Missing 1 0.1     
Employment Status         
 Retired/Unemployed 427 57.6 150 35.8 277 86.0 .000 
 Employed 314 42.4 269 64.2 45 14.0 
Annual Income (US 
$) 
       
 < 30,000 202 27.3 93 22.2 109 33.9 .000 
 30,000–59,999 228 30.8 111 26.5 117 36.3 
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 60,000–89,999 131 17.7 89 21.2 42 13.0 
 ≥ 90,000 180 24.3 126 30.1 54 16.8 
Disease 
Characteristics  
       
NHL Histology        
 Indolent  365 49.3 202 48.2 163 50.6 .244 
 Aggressive 335 45.2 200 47.7 135 41.9 
 Missing  41 5.5 17 4.1 24 7.5 
Stage at Diagnosis        
 I 204 27.5 108 25.8 96 29.8 .249 
 II 137 18.5 78 18.6 59 18.3 
 III 125 16.9 79 18.9 46 14.3 
 IV 178 24.0 108 25.8 70 21.7 
Missing  97 13.1 46 11.0 51 15.8  
Currently in 
Remission  
       
 Yes 579 78.1 321 76.6 258 80.1 .415 
 No 97 13.1 60 14.3 37 11.5 
 Don’t Know 63 8.5 38 9.1 25 7.8 
Missing  2 0.3 5  2 0.6 
Currently receiving  
treatment  
       
 Yes 105 14.2 69 16.5 36 11.2 .041 
 No 636 85.8 350 83.5 286 88.8 
Treatments Received         
 Chemotherapy 592 79.9 340 81.1 252 78.3 .331 
 Radiation therapy 358 48.3 214 51.1 144 44.7 .086 
 Surgery 223 30.1 133 31.7 90 28.0 .245 
 Biologic therapy 223 30.1 150 35.8 73 22.7 .000 
 Bone marrow/stem  
 cell transplantation  
116 15.7 95 22.7 21 6.5 .000 
 Other therapy 87 11.7 54 12.9 33 10.2 .269 
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Missing surgery 
variable 
18 2.4 11 2.6 7 2.2  
Comorbid Scores         
0 86 11.4 73 7.4 13 4.0 .001 
1 141 18.7 97 5.2 44 13.5 
2 137 18.2 80 0.8 57 17.4 
≥ 3 389 51.5 176 23.3 213 28.3 
Total lifetime medical 
conditions (range 0–
30) 
5.6 
(4.8) 
 4.6 
(4.5) 
 6.8 
(5.1) 
  
Mean age at time of 
study (range 21–90) 
62.3 
(13.4) 
 53.1 
(9.3) 
 74.4 
(6.4) 
  
Years since diagnosis 
(range 2–44) 
10.2 
(7.1) 
 9.6  
(6.3) 
 11.2 
(7.9) 
  
Note. Numbers given in parenthesis are standard deviations.
 
  
 
Research Question 1: Does age moderate relationships between demographic and disease 
characteristics and QOL for NHL survivors? 
 The demographic characteristics included in the regression model were gender 
(female), income (< $30,000 or ≥ $30,000 annually), education (college graduate or not),and  
employment status (employed or unemployed or retired). The disease factors were 
comorbidity scores, currently receiving treatment, types of cancer treatments received (bone 
marrow transplant, biologic therapies, or both), and years since diagnosis. 
 Female gender was associated with 1.8 point increase in FACT-G score, college 
graduates had a 2.4 point increase in FACT-G score, and those who were employed had a 2.7 
point increase in FACT-G score over those who were unemployed or retired while earning 
less than $30,000 was associated with a 6.0 point decrease in FACT-G score.  For every point 
increase in comorbidity score, the FACT-G score decreased by 1.4 points. Those who were 
currently receiving treatment had a lower FACT-G score by 4.9 points, those who had 
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received a BMT had a 4.5 point decrease in FACT-G score, those who had received biologic 
therapy had a 2.7 point decrease in FACT-G score while longer time since diagnosis was 
associated with a higher FACT-G score, with a .16 point increase for every year since 
diagnosis. 
 There were two demographic characteristics/disease factors whose relationships with 
QOL were significantly moderated by age: income and gender. Lower income is associated 
with lower FACT-G score, but this effect was not as strong in older survivors. Younger 
women had higher FACT-G scores than younger men, but the difference was not as large in 
older survivors (9.8 points). The moderating effect was not statistically significant in the full 
model.  
 
Table 4.2 
 
Age as a Moderator of the Demographic and Disease Factor Relationships with Quality of 
Life 
Characteristics  Regression Model with 
moderation 
Moderation with Age 
B (SE) P value B (SE) P value
Gender: Female 1.87 0.08 10.34 0.04 
Income: < $30,000 -6.03 <.0001 -24.1 <.0001 
Education: College 
Graduate  
2.47 0.05 2.71 0.03 
Employed 2.78 0.03 1.98 0.13 
Comorbidity Score -1.35 <.0001 -1.35 <.0001 
Currently Receiving 
Treatment  
-4.84 0.00 -4.92 0.00 
Cancer Treatments: Bone 
Marrow Transplant 
-4.58 0.00 -4.86 0.00 
Cancer Treatment: 
Biologic 
-2.68 0.03 -2.82 0.02 
Years Since Diagnosis 0.155 0.04 0.125 0.10 
Female* Age -  -0.13 0.08 
Income *Age -  0.284 0.00 
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Figure 4.1. Final age moderation model. 
 
Discussion 
The goal of the study was to examine the moderating role of age on the relationship 
between demographic and disease factors and QOL in NHL survivors. The sample was 
evenly distributed with numbers of males and females, 50% each. While NHL is more 
common in older adults than younger adults with an unpredictable illness trajectory, we 
found that younger survivors had a more difficult time with their cancer diagnosis than older 
survivors.  
This study fills an important gap in the NHL literature about younger survivors and 
the association that demographic characteristics have on QOL. Breast cancer survivorship 
literature has explored the impact of cancer in younger survivors more than any other cancer, 
and this is the first NHL study to explore age and its relationship on QOL, specifically in 
younger survivors with NHL. 
 The disease is not gender specific, and its unique characteristics expand across ages. 
The effect of income on QOL was significantly moderated by age and though the effect of 
gender was not significantly moderated by age in the full model, there still may be clinical 
relevance for genders. Being a female, being a college graduate, being employed, and having 
Demographics  
 
Annual Income           
(< $30, 000) 
 
 
Quality of Life  
 
Physical 
Social/Familial 
Age 
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a longer time since diagnosis all had positive associations with QOL, whereas, earning less 
than $30,000 annually, having higher comorbidity scores, currently receiving treatment, 
having had a bone marrow transplant, and having had biologic therapy all had negative 
associations with QOL. These associations support findings from other studies that have 
explored these demographic and disease characteristics. Those without a college degree may 
be more likely to terminate their job due to physical demands at their place of employment 
and less flexibility in hours compared with those who have a college degree (Abrandt et al., 
2004; Hartl et al., 2003).  
 Younger survivors who made less than $30,000 had poorer QOL than older survivors 
who earned the same amount. This finding is supported by Bellizzi et al. (2007) who reported 
that survivors with NHL reported negative economic changes as a result of having a cancer 
diagnosis. Sixty percent of the current sample were younger survivors, and more than half 
employed (64%). Another study reported that survivors who maintained their employment 
status reported higher physical QOL compared to those who reduced their work hours or 
stopped working completely (Mols, Thong, Vreugdenhil & van de Poll-Franse, 2010).  
 Forty-one percent of the participants in the same study reported a change in 
employment status and decline in QOL status due to their cancer, along with problems 
obtaining insurance or a mortgage. Employment and income are ongoing social and financial 
concerns faced by survivors and future work that explores their long term impact on QOL is 
needed. These results suggest that younger women diagnosed with NHL are more likely than 
their older counterparts to experience psychological distress and poorer QOL related to their 
disease and its treatment due to financial constraints.  
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Other studies support that younger breast cancer survivors felt that their diagnosis has 
limited their family, career, and lifestyle priorities (Stewart et al, 2001; Thewes, Butow, 
Girgis, & Pendlebury, 2004). This finding has implications for both younger and older 
survivors, but focused economic implications are greater for younger survivors who have 
competing demands with career aspirations compared to those who may be retired. 
Increasing social support systems can increase QOL to favorably impact overall survival in 
younger breast cancer survivors (Chou, Stewart, Bloom, & Koo, 2003). 
There are several plausible explanations for why younger female survivors have 
lower QOL than their older counterparts. Younger survivors are often diagnosed at a time 
when they have multiple responsibilities with their family (e.g., primary caregiver for their 
spouse, parent, or child), working in or outside of the home, and/or maintaining their career 
aspirations. Additionally, younger survivors usually have fewer coping skills to manage their 
diagnosis and the thought of an early death may contribute to greater distress and poorer 
QOL.  
 This secondary analysis is cross sectional in nature so we cannot establish a cause-
effect relationship between demographic and disease characteristics and QOL, however we 
are able to assess the strength of the associations. A longitudinal study may provide a more 
convincing answer to the question of whether demographic and disease characteristics impact 
QOL changes with increasing age. Increasing age does not mean that QOL will be reduced, 
but future studies are needed to look at age differences across cancer populations with 
various sociodemographic and disease variables. The strength of this study is the use of an 
existing large dataset of NHL survivors to answer questions about a unique and understudied 
cancer population. Data is self-reported. These data provide a source of population-based 
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information about NHL cancer survivorship in North Carolina.  Additionally, the large 
sample provided age stratification that allows for inferences for the age groups. Future 
studies could include other moderating effects on QOL such as comorbidities, gender, and 
income. In addition, studies could stratify younger age groups to assess for QOL differences 
and intervene appropriately if one age group has poorer QOL. 
 The strength of this study is the use of an existing, large data set of NHL survivors to 
answer questions about a unique and understudied cancer population.  These data provided a 
source of population-based information about NHL cancer survivorship in North Carolina. 
Additionally, the large sample provided age stratification that allowed for inferences among 
age groups. Future studies could include other moderating effects on QOL such as 
comorbidities, gender, and income. In addition, studies could stratify younger age groups to 
assess for QOL differences and intervene appropriately if one age group has poorer QOL.  
Conclusion 
 Age is an important moderator of the effects of QOL. Our findings demonstrate that 
the association between income and QOL was more prominent in younger survivors. This 
difference clearly warrants the development of resources and interventions sensitive and 
specific to age-related issues unique to younger NHL cancer survivors. This difference 
clearly warrants the development of resources and interventions sensitive and specific to age-
related issues unique to younger NHL cancer survivors 
 84 
 
REFERENCES 
Abrandt, T., Martikainen, R., Virtanen, S., Pukkala, E., Hietanen, P., & Lindbohm, M. 
(2004). The impact of education and occupation on the employment status of cancer 
survivors. European Journal of Cancer, 40, 2488–2493. 
 
Avis, N., Smith, K., McGraw, S., Smith, R., Petronis, V., & Carver, C. (2005). Assessing 
quality of life in adult cancer survivors (QLACS). Quality Life Research, 14, 1007–1023. 
Bennett, J.  (2000). Mediator and moderator variables in nursing research: Conceptual and 
statistical differences. Nursing Research, 23, 415–420. 	
 
Chou, A., Stewart, S., Bloom, J., & Koo, J. (2003). Survival in young women with breast  
cancer: The effect of social support. Unpublished manuscript. 
 
Fortin, M., Bravo, G., Hudon, C., Lapointe, L., Almirall, J., Dubois, M., & Vanasse, A. 
(2006). Relationship between multimorbidity and health-related quality of life of 
patients in primary care. Quality of Life Research, 15(1), 83–91. 
 
Ganz, P., Rowland, J., Desmond, K., Meyerowitz, B., & Wyatt G. (1998). Life after breast 
cancer: Understanding women’s health-related quality of life and sexual functioning. Journal 
of Clinical Oncology, 16, 501–514. 
 
Ganz, P., Guadagnoli, E., Landrum, M., Lash, T., Rakowski, W. & Silliman, R. (2003). 
Breast cancer in older women: Quality of life and psychosocial adjustment in the 15 months 
after diagnosis. Journal of Clinical Oncology, 21, 4027–4033. 
 
Hartl, K., Janni, W., Kastner, R., Sommer, H., Strobl, B., Rack, B., & Stauber, M. (2003). 
Impact of medical and demographic factors on long-term quality of life and body image of 
breast cancer patients. Annals of Oncology, 14, 1064–1071. 
 
Hewitt, M., & Simone, J. (1999). Ensuring quality cancer care. Washington, DC: National 
Academy Press. 
 
Karakiewicz, P. I., Bhojani, N., Neugut, A., Shariat, S. F., Jeldres, C., Graefen, M., . . .  
Kattan, M. W. (2008). The effect of comorbidity and socioeconomic status on sexual and 
urinary function and on general health-related quality of life in men treated with radical 
prostatectomy for localized prostate cancer. Journal of Sexual Medicine, 5(4), 919–927. 
 
Ko, C., & Chaudhry, S. (2002). The need for a multidisciplinary approach to cancer care. The 
Journal of Surgical Research, 105, 53–57. 
 
Kroenke, C., Rosner, B., Chen, W., Kawachi, I., Colditz, G., & Holmes, M.  (2004). Journal 
of Clinical Oncology, 22, 1849–1856. 
 
 85 
 
Mols, F., Thong, M., Vreugdenhil, G. & van de Poll-Franse, L. (2009). Long-term cancer 
survivors experience work changes after diagnosis: Results of a population-based study. 
Psycho-Oncology, 18, 1252–1260.  
 
National Cancer Institute. (2011). US cancer survivors grows to nearly 20 million. Retrieved 
from http://www.cancer.gov/newscenter/pressreleases/2011/survivorshipMMWR2011 
 
National Coalition for Cancer Survivorship. (n.d.) The organization. Retrieved from 
http://www.canceradvocacy.org/about/org/ 
 
Naus, M., Ishler, M., Parrott, C., & Kovacs, S. (2009). Cancer survivor adaptation model: 
Conceptualizing cancer as a chronic illness. Journal of Clinical Psychology, 65(12), 1350–
1359.  
Parsons, S., &  Mayer, D. (2004). Health-related quality of life assessment in hematologic 
disease. Hematology/Oncology Clinics of North America,18(6): 1235–48. 
 
Sangha, O., Stucki, G., Liang, M., Fossel, A., & Katz, J. (2003). The self-administered 
comorbidity questionnaire: A new method to assess comorbidity clinical and health services 
research. Arthritis Rheumatology,49, 156–163.  
 
Stewart, A., Mills, K., King, A., Haskell, W., Gillis, D., & Ritter, P. (2001). CHAMPS 
physical activity questionnaire for older adults: Outcomes for interventions. Medicine and 
Science in Sports and Exercise, 33, 1126–1141. 
 
Thewes, B., Butow, P., Girgis, A., & Pendlebury, S. (2004). The psychosocial needs of breast 
cancer survivors: A qualitative study of the shared and unique needs of younger versus older 
survivors. Psycho-Oncology, 13, 177–189. doi:10.1002/pon.710 
 
Yancik, R., & Ries, L. (2000). Aging in America: Demographic and epidemiologic 
perspectives. Hematology Oncology Clinics of North America, 14, 17–23.  
 
Yancik, R., Ganz, P., Varricchio, C., & Conley, B. (2001). Perspectives on comorbidity and 
cancer in older patients: Approaches to expand the knowledge base. Journal of Clinical 
Oncology, 19, 1147–1151. 
 
  
 
CHAPTER 5 
FINDINGS AND IMPLICATIONS 
 
 
 There are nearly 12 million cancer survivors in the US, and 438,325 of them are non-
Hodgkin lymphoma (NHL) survivors (National Cancer Institute, 2010). As the population 
ages and increases, survivors will live longer with this disease. Cancer coupled with 
comorbid illnesses and the long-term effects of both diseases will be issues NHL survivors 
will face. The impact of cancer usually extends beyond the physical, influencing 
psychological and social functioning to the point that all aspects of life may be adversely 
affected. It is therefore reasonable to conclude that cancer can adversely influence survivors’ 
lives in the area of psychological adaptation.  
 This concept of adaptation to cancer can be seen in the cancer survivor adaptation 
(CSA) model that encompasses personal and demographic characteristics, positive and 
negative adaptations to cancer, and the impact of them all on quality of life (QOL) outcomes 
(Naus, Ishler, Parrott, & Kovacs, 2009). The purpose of this dissertation was to explore the 
relationships between demographic and disease characteristics and QOL and to examine the 
impact that a cancer diagnosis has on survivorship, specifically for NHL survivors.  
 The review of literature findings (Leak, Mayer, & Smith, 2011) on NHL survivors’ 
QOL led me to explore the unique issues of older adults with NHL. The literature findings 
and clinical perspectives drew me to explore and understand how NHL survivors perceive 
their disease during a time of uncertainty. As the population of NHL survivors grows, 
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research focused on QOL-related outcomes for older adults is needed. Thus, this dissertation 
study was conducted.  
Conceptual Framework 
 The framework for this study was based on the CSA model derived from Naus, Ishler, 
Parrott, and Kovacs’s (2009) research. It has three components: personal characteristics, 
adaptation, and outcomes. The three variables that depict relationships between those 
components are represented in the CSA model: personal characteristics, adaptation during the 
illness, and cancer-specific QOL outcomes (Figure 5.1). Personal characteristics include the 
biological, psychological, social, and spiritual factors that impact the cancer experience. 
Adaptation is the fundamental component of this model and is an ongoing, cognitive process 
involving continuous appraisal of the situation by the survivor (Naus et al., 2009). It is 
reflected as the positive and negative impacts of cancer. Quality of life is the outcome of the 
model. 
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 Personal Characteristics   Adaptation   Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. The cancer survivor adaptation model illustrating the three components and three 
variables that affect positive and negative adaptations of survivors to their cancer diagnoses 
and treatments. Source: Adapted from Naus, Ishler, Parrott, and Kovacs, 2009. BMT = bone 
marrow transplant, SCT = stem cell transplant.  
 
 
All of these variables can influence survivors’ adaptations to cancer, and understanding their 
relationships will help to address the multifaceted health needs of NHL survivors.  
Sample 
 This secondary data analysis used cross-sectional data that provided a large 
geographical sample for exploring relationships between personal characteristics and QOL, 
mediations between personal characteristics and QOL, and the effect of age on the QOL of 
NHL survivors. Approval was obtained from the University of North of North Carolina at 
Chapel Hill Institutional Review Board. Data on the survivors were collected from 2005–
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2006 through mailed surveys, supported by a R03-CA-101492 NCI grant for the Quality of 
Life of Older Long-Term Lymphoma Survivors study (Sophia Smith, Principal Investigator). 
The cancer survivors were predominately Caucasian and married or living with a partner. 
The sample was recruited from survivors treated at two comprehensive cancer centers in the 
southeastern United States: the Duke University Medical Center and the University of North 
Carolina at Chapel Hill Lineberger Center. More than half were employed or had a college 
degree. The average age of the survivors was 62.4 (SD 13.3), and they were an average of 
10.1 (SD 7.1) years postdiagnosis.  
Aim 1 
To explore demographic and disease characteristics associated with quality of life for non-
Hodgkin-lymphoma survivors 
 The CSA model proposed that personal characteristics, which include demographic 
and disease factors, can have a direct positive or negative association with QOL. Poorer QOL 
was seen in those who were male, had less than a college degree, had an annual income of 
less than $30,000, and were unemployed or retired. Significant disease characteristics 
associated with poorer QOL included higher total comorbidity scores, some treatment types 
(bone marrow transplantation [BMT] or stem cell transplantation  [SCT], biologic therapy), 
and fewer years since diagnosis. The final regression model indicated that QOL was worse 
for survivors who were males, who were younger at the time of the study, had a greater 
comorbidity burden, had received a BMT, or SCT, or biologic therapy, or had been 
diagnosed more recently (p < .05).  
 These findings are similar to other cancer population studies wherein survivors who 
were younger at the time of the study or diagnosis, had a higher number of comorbidities, 
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and those who were recently diagnosed had poorer QOL. These associations identify a group 
of NHL survivors at higher risk for poor QOL who should be targeted for assessment and 
intervention. These variables accounted for 34% of the variance of QOL, with 66% of the 
variance remaining unexplained, indicating that other key variables were absent. Other 
characteristics that might influence QOL and could be included in future studies are social 
support, spiritual and existential influences, and insurance issues. The significant 
relationships found in this aim are modeled in Figure 5.2.  
 
     Personal Characteristics              Outcomes 
 
 
 
 
 
Figure 5.2. Final regression model with all significant variables (p < .05). BMT = bone 
marrow transplantation, SCT = stem cell transplantation. 
 
 
Aim 2 
To test a conceptual model to determine if adaptation to a cancer diagnosis mediated the 
relationship between demographic and disease characteristics and quality of life 
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 The CSA model was the guiding model to determine how adaptation to cancer 
mediated relationships between demographic and disease characteristics and QOL. This 
adaptation is an ongoing, cognitive process involving continuous appraisal by the survivor 
and is reflected as positive and negative adaptation (Naus et al., 2009; Zebrack, Ganz, 
Bernaards, Petersen, & Abraham, 2006). Positive adaptation has favorable psychosocial 
implications, such as better coping skills, and encompasses these positive aspects: altruism 
and empathy, health awareness, understanding the meaning of cancer, and positive self-
evaluation. Negative adaptation focuses on appearance concerns, body change concerns, life 
interferences, and worry with unfavorable physical or psychological outcomes (Zebrack et 
al., 2006). The Impact of Cancer (IOC) scale used in the parent study conceptualizes the 
cancer experience as perceptions. Relationships between personal characteristics and QOL 
outcomes can be mediated through positive or negative adaptation to the illness. Personal 
characteristics are represented by personal characteristics (demographic and disease factors), 
positive adaptation or negative adaptation, and outcomes of cancer-specific QOL. Our 
findings supported the coexistence of positive and negative perceptions, and negative 
adaptation to cancer resulted in a stronger mediating effect than positive adaptation to cancer. 
These findings add to the limited evidence on the presences of both types of adaptation 
(Bower et al, 2005).  
 Survivors of NHL may go through an intermittent exacerbation and remission cycle 
or a downward illness trajectory complicated by the presence of multiple comorbid 
conditions. Some NHL survivors, dependent on whether the lymphoma is slow growing or 
aggressive, are more apt to endure a longer treatment process with unknown disease 
progression or remission and uncertainty. The statistical approach used to clarify the nature 
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between the independent variables (personal characteristics) and dependent variables (QOL 
outcomes) was mediation (Baron & Kenny, 2006). Mediation represents processes that could 
potentially be targeted for interventions to influence QOL outcomes.  
 Using the CSA model, we identified higher risk groups for poorer QOL. The model 
suggested that older survivors could be targeted for interventions aimed at the negative 
mediators (negative perceptions), and survivors  without a college degree, with a higher 
comorbidity score, with a more recent diagnosis, currently receiving treatment, and who are 
younger might benefit from psychological counseling or cognitive behavioral therapy as a 
means to improve their QOL. Additionally, survivors who have received a BMT, SCT, or 
biologic therapy may also benefit from interventions focused on enhancing management of 
symptoms or late effects from treatment and cancer. Such treatment might reduce negative 
thoughts and improve QOL. The structural equation modeling (SEM) used in this aim 
provided support for the concept of postcancer diagnosis experiences being simultaneously 
shaped by both positive and negative life changes with varying adaptation trends occurring 
over time.  
Aim 3 
To determine whether age moderated the effects of demographic and disease characteristics 
on quality of life 
 Moderators are variables that change the impact of one variable on another (Baron & 
Kenny, 2006). A moderation model was used for this aim to determine how personal 
characteristics change the impact of QOL with age as a moderator. Advancing age is the 
most-associated risk factor for cancer, with a median age of 67 for NHL diagnoses 
(Surveillance and Epidemiology and End Results, 2010). The analyses included a 
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comparison of the effects of personal characteristics in younger (< 65 years of age) and older 
(> 65 years of age) survivors. Age was found to be a moderator of the relationships between 
income and QOL and gender and QOL. The associations between being male or having low 
income and QOL were stronger in the younger participants than in the older participants. 
Strengths and Limitations 
 In my literature review of 18 studies on NHL survivors and QOL domains (Leak et 
al., 2011), and in Arden-Close, Pacey, and Eiser’s literature review (2010), methodological 
issues related to small sample sizes, lack of conceptual or theoretical models, and no 
longitudinal studies for comparing changes over time were raised. As a cross-sectional study, 
the parent study for this research did not capture information about changes over time; 
nonetheless, the large sample of survivors provided a unique opportunity to explore the 
psychological distress of NHL survivors within the CSA theoretical framework. The parent 
study used a cancer-specific QOL measure, the Functional Assessment Cancer Therapy-
General (FACT-G), and was able to capture the QOL of NHL survivors. However, additional 
QOL measures should be considered that include more diverse QOL domains and cultural 
representation. One strength of the study was the large database that consisted of 40% older 
adults (> 65 years old), a large enough subsample to allow for comparisons with younger 
survivors (< 65 years old). However, there was a high percentage of missing data noted in the 
disease stage category. The NHL sample also had high socioeconomic statuses, and over 
50% had a college degree.  
 The regression and SEM models contributed an adequate fit, but other theoretical 
models and methods of analysis may yield a better fit and should be considered in future 
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studies. Replication studies in other geographical areas with other types of cancers are 
needed to validate the roles of positive and negative adaptation in the QOL of survivors. 
Implications for Research 
 The findings of this study indicate several areas for future scientific inquiry. Although 
coexisting comorbidities had a significant effect on these survivors’ health, the longitudinal 
relationships between NHL and management of noncancer conditions have not been fully 
investigated. One recommendation for future studies is to use medical records in addition to 
self-reports to investigate comorbidities among cancer survivors. Medical records may 
provide additional information to validate the severity of the comorbidity self-reported. 
Additionally, future analyses to look at each FACT-G QOL domain may provide a more 
nuanced appreciation of how mediators affect specific aspects of QOL, providing more in-
depth assessments of these associations.  
Other research studies could include looking at subsamples of survivors with 
recurrences or actively on treatment and comparing their ability to adapt to the disease with 
survivors in remission not receiving treatment. Additional analyses could include racial and 
ethnic minority groups’ adaptation to NHL as compared to Caucasians to determine if there 
is a difference in QOL. Also, there is no matched control study for comparing psychosocial 
adaptation and QOL to determine if these survivors have a better or worse status than  a 
similar group who never had cancer.  
 Further studies could include mixed-methods studies that explore the experiences of 
NHL survivors. Research supports spirituality’s important effect on health and QOL; 
however, what extent it has on health remains an area for further investigation (Efficace & 
Marrone, 2002; Powell, Shahabi, & Thoresen, 2003). Many studies involving religious and 
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spiritual well-being are cross-sectional, which makes it difficult to prospectively understand 
the relationships. As a result, future studies should be prospective, including variables that 
might mediate the relationship between spirituality and the physical and emotional domains 
of QOL.  
 Two of the noted limitations of the NHL survivorship literature (Leak et al., 2011) are 
the lacks of longitudinal studies following survivors over time and the underrepresentation of 
minorities. Given that this study was cross-sectional, it provided insight for prospective 
studies in the development of longitudinal and intervention studies. Future studies to include 
survivors’ abilities to adapt to cancer changes over time would be beneficial in determining 
how and when to intervene. To address the question on how survivors adapt differently 
throughout their illness trajectory, Dr. Sophia Smith has collected 5-year follow-up data on 
NHL survivors. These data will be compared to baseline data (2004–2005) to retest the CSA 
model and evaluate QOL domain outcome changes. Interventions may be identified, 
developed, and implemented. From this study, positive and negative perceptions have been 
identified as potential areas for interventions to improve the QOL of NHL survivors, with 
negative adaptation having a stronger mediating effect on QOL.  
Implications for Practice 
 
 These findings are consistent with previous studies that found that while most 
survivors adjust to living with NHL, there remain subsamples of survivors who suffer from 
psychosocial distress from their cancer diagnosis (Tedeschi, Park, & Calhoun, 1998). Only 
the survivor living the life can describe his or her QOL and the impact it has on daily living. 
Subsequently, QOL should not be judged by others but needs to be understood from the 
perspective of the person living as a cancer survivor (Parse, 1998). Both social and functional 
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QOL domains remain areas that affect interpersonal relationships, employment, finances, 
abilities to obtain insurance, and reintegration into the social environment. Although income 
cannot easily be augmented, it is suggested that continued efforts to increase access to 
affordable health insurance and care remain important for long-term recovery. How survivors 
perceive their illness can influence their functional and physical abilities, which can impede 
or enhance their QOL.  
 In the CSA model, fewer years since diagnosis was correlated with poorer QOL, 
indicating that survivorship issues occur throughout the illness trajectory but may be more 
intense closer to the diagnosis and initial treatment. The negative psychosocial problems 
faced by survivors may not always be recognized by healthcare providers, but ongoing 
screening and assessments is recommended. Thus, healthcare providers must provide 
information about healthy behaviors, such as physical activity and exercise, to guide the 
survivor throughout the illness trajectory. Vallance, Courneya, and Jones (2006) found that 
150 minutes per week of physical activity was associated with improved QOL, and 
ultimately, favorable physical and psychological well-being for NHL survivors. Some 
survivors have positive and negative experiences from their health behaviors, but additional 
work is needed to determine the relationship between those experiences. Nevertheless, some 
survivors still experience poorer functioning than others, and nurses should inquire about 
lifestyle behaviors to provide management or counseling for them. 
Conclusion 
 
 Several characteristics were identified that were significantly related to adaptation to 
NHL and poorer QOL. The results of this study suggest that both positive and negative 
adaptation mediate the relationships between demographic and disease characteristics and the 
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QOL of NHL survivors. Thus, it would be reasonable to hypothesize that cognitive reframing 
(Mishel, 1990) to promote better QOL could be an effective, tested cognitive method for 
cancer survivors. The CSA model supported the importance of exploring the role of 
adaptation in QOL outcomes. 
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